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PREFACE
This thesis describes several studies on Helicobacter pylori which sought to 
correlate toxinogenicity and host immune inflammatory responses.
Parts of this work have been already published. Reprints are submitted with the 
thesis. Some of the work has also been presented to several learned societies. 
The help and contribution by colleagues and others are formally acknowledged.
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SUM M ARY
Despite the widespread recognition of the role of H. pylori infection in chronic 
gastritis and peptic ulceration, the mechanisms by which the bacterium induces
■ :
mucosal damage and the apparent different outcome in infected patients are still 
not well understood. It has been suggested that the toxinogenicity of H. pylori 
and the host response may be important in these respects.
Neutrophil fonction is an important host defence mechanism against microbial
infection. It provides a major source of reactive oxygen metabolites which are known
to cause tissue damage. H. pylori has been shown to activate neutrophils and there are
variations among H. pylori strains in the neutrophil activating activity. It is not known
,if cytotoxin-producing strains of H. pylori are associated with the generation of an 
oxidative burst in neutrophils. This has been investigated in this thesis. Cytotoxin 
positive strains of H. pylori displayed an entranced induction of the oxidative burst in
14
.non-opsonised neutrophils compared to toxin negative strains from patients with
clu'onic gastritis only. However, some non-cytotoxin-producing strains also induced a 
significant neutrophil oxidative burst, suggesting that some component(s) other than 
cytotoxin itself may be responsible for the induction of the neutrophil oxidative burst. 
Nevertheless the finding that cytotoxin-producing strains of H. pylori induced an 
enlianced neutrophil respiratory burst may suggest that the neutrophil activating 
property may be more strongly expressed in most toxinogenic strains of H. pylori. The 
ability of some strains of H. pylori to produce cytotoxin and to induce the oxidative 
burst in neutrophils may be important in the pathogenesis of peptic ulcer disease .
I
Subsequent study investigated the possible component(s) of H. pylori which 
induces the neutrophil oxidative burst. It was found that soluble products o f H. I
pylori could activate neutrophils to release ROM and more than one bacterial 
product may be involved in the activation of neutrophils. The results also 
showed that the neutrophil activating activity was destroyed by proteinase K,
suggesting that the active components are mainly proteins. Cytotoxin and urease i
containing fractions from chromatography did not induce a significant CL
response, suggesting that the cytotoxin and/or urease are not the active 3
components for the neutrophil activation. IIn vitro studies have suggested that toxinogenic strains of H. pylori, which possess L
CagA(cytotoxin-associated protein) and/or VacA(vacuolating cytotoxin), may induce 
a more potent inflammatory response, evidenced by an enhanced induction of 
interleukin 8(IL-8) and neutrophil oxidative burst. It is unclear whether there is any 
relationship between in vivo mucosal production of IL-8 and neutrophil-derived 
reactive oxygen metabolites(ROM) release and whether mucosal levels of IL-8 and 
ROM are increased in those patients infected with toxinogenic strains. It has been 
shown in this thesis that there is a good correlation between IL-8 concentration A
and ROM release in antral gastric mucosa. This suggests that local mucosal 
production of IL-8 in response to H. pylori infection does occur in vivo and may i
play an important role in attracting and activating phagocytes to release ROM.
In line with the in vitro finding that VacA+/cagA+ strains induced an enhanced IL-8 | |
='■
production in epithelial cells, patients infected with VacA+ve/cagA+ve strains had I1significantly higher mucosal levels of IL-8 than those infected with VacA-ve/cagA-ve Istrains of H. pylori. The former group of patients also showed a significantly higher 1
15 ■
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neutrophil infiltration score than that of the latter group. CagA+ve/VacA+ve strains 
may represent a subgroup of strains of H. pylori which stimulate a stronger cytokine 
release in vivo and induce more severe mucosal inflammation and tissue injury. This 
is supported by the finding that patients infected with VacA+ve/cagA+ve strains 
had a higher mucosal production of ROM compared to those infected with
■ P '  'T'
VacA-ve/cagA-ve strains of H. pylori. More toxinogenic strains were isolated A
16
from patients with peptic ulcer compared to those with non-ulcer dyspepsia (NUD). M
The results support the hypothesis that there may be more virulent or 
'ulcerogenic' strains. Enhanced mucosal production of IL-8 and ROM could be 
important in VacA+ve/cagA+ve strains of H. pylori-inàwooé. gastroduodenal i|v
inflammation and in the development of peptic ulcer disease.
Generation of mucosal IgA is an important local immune defence mechanism. H. 
pylori induces a significant IgA response in antral mucosa in infected patients. Despite 
the persistent local and systemic immune response, H. pylori is not eliminated.
However, animal studies suggest the mucosal IgA antibodies may be protective. There 
is little infomiation as to the relationship if any between mucosal IgA H. pylori
antibodies and toxinogenicity of H. pylori and mucosal inflammation. It has been A
shown in this thesis that most infected patients had raised mucosal levels of IgA II
antibodies. While there were large variations in the level of IgA antibodies among L
■S’patients, there was no significant difference between patients infected with VacA+ve f
#or cagA+ve strains and those infected with Vac A-ve or cagA-ve strains. Lack of A
correlation between the mucosal antibody and the toxinogenicity of H. pylori may |
1suggest that differences in individual host response may be more important. The time S
of infection may also be relevant. The finding that the mucosa with severe infiltration
• ■ ' ■ - a . . ! . . . . .  .h " .  - ;
score of neutrophils displayed lower level of IgA compared to the mucosa with mild 
to moderate infiltration may suggest that severe inflammation could damage the 
integrity of the mucosa and compromise the mucosal defence. Tliis may render the 
mucosa more susceptible to injury.
There have been few studies on the effect of eradication therapy of H. pylori on the 
mucosal levels of IL-8, ROM and IgA. In this thesis, 24 patients with duodenal ulcer 
and infected with H. pylori were treated with an eradication regime consisting of 
lansoprazole, clarithromycin and metronidazole. In 20 patients in whom H. pylori 
were eradicated, there was a significant reduction in mucosal ROM levels. There was 
a less marked but significant decrease in mucosal levels of IL-8. There was also a 
slight reduction in IgA levels. A significant improvement was seen in histological 
appearance with the virtual disappearance of neutrophil infiltrate in all patients who 
became culture-negative for H. pylori, and a moderate reduction in the level of 
mononuclear cell infiltrate. These findings support the roles of IL-8 and ROM in H. 
pylori infection. A sustained level of mucosal specific IgA might be important in 
preventing reinfection by H. pylori.
In summary, toxinogenic strains of H. pylori are more likely to induce a 
stronger host inflammatory response by inducing an enhanced neutrophil 
oxidative burst and an enhanced mucosal production of IL-8 and ROM, leading 
to a more prominent mucosal inflammatory cell reaction. More severe mucosal 
inflammation may damage the mucosal IgA defence, rendering the mucosa more 
susceptible to infection and injury. These findings may be important in the 
pathogenesis of H. py/oW-related active gastritis and peptic ulcer disease.
17
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CHAPTER 1 Background
1.1 Introduction
Since the finding of the Campylobacter-like organism, now known as 
Helicobacter pylori{H. pylori) in 1983 by Marshall and W arren(l,2), the 
understanding of the pathogenesis of chronic gastritis and peptic ulcer has been 
greatly enhanced by the recognition of H. pylori as the most important cause of 
chronic gastritis and an important factor in the development of peptic ulcer(3-5). 
Evidence has come from the following —  H. pylori infected mucosa almost 
always displays histological inflammation; almost all patients with duodenal 
ulcer and the majority of patients with gastric ulcer are colonised with H. pylori 
(6), and eradication of the organism leads to a significant reduction in 
histological inflammation and in the rate of ulcer relapse(7). Studies of the 
epidemiology, bacteriology and immunology, pathophysiology and molecular 
biology have significantly increased our knowledge of H. /?y/orLrelated 
gastroduodenal disease, such as chronic gastritis and peptic ulcer, although the 
exact mechanisms by which H. pylori induces gastroduodenal mucosal 
pathology are still not fully understood. This chapter reviews the current 
understanding of the pathogenesis of H. py/ori-related chronic gastritis and 
peptic ulcer.
1.2 Chronic gastritis
1.2.1 Definition
Chronic gastritis refers to the chronic inflammatory response of the gastric 
mucosa to infection or injury, characterised by infiltration of lymphocytes, and
18
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plasma cells often accompanied by polymorphonuclear cells. It is usually
diagnosed histologically from gastric biopsies.
1.2.2 Classification and pathogenesis
Recent advances in the understanding of the pathogenesis of gastritis and 
especially the role of H, pylori have made it possible to classify gastritis more 
comprehensively. Previously, it was classified as type A gastritis(i.e.
19
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autoimmune gastritis), Type B gastritis(‘bacteriaT gastritis) and type C
gastritis(‘chemical’ or reflux gastritis) which was associated with bile reflux
,and possibly non-steroidal anti-inflammatory drugs(NSAID)(8). A new 
classification scheme —  the Sydney system, which was drawn up at the 9th 
World Congress of Gastroenterology in Sydney in 1990, provided a more 
comprehensive and descriptive way to classify gastritis, which included 
histological and endoscopic divisions(9-10). For the histological classification, 
it included aetiology and topographical distribution of abnormalities and 
morphologies.
According to different aetiologies, it could be classified into the following 
categories, although there is some overlap between them,
Helicobacter pylori-as so dated chronic gastritis
It is by far the commonest type of chronic gastritis(4). It was known as chronic 
non-specific gastritis until 1983 when Warren and Marshall highlighted its 
strong association with H. pylori{3). The mucosa of the gastric antrum is 
primarily affected, although extension into the body is not uncommon in long- 
standing cases. Histologically, there is a chronic infiltration of lymphocytes 
and plasma cells, often accompanied by a superimposed patchy or diffuse acute
inflammatory cell infiltrate comprising mainly neutrophils, largely confined to
the superficial part of the mucosa and the surface epithelium. Focal aggregation 
of lymphocytes as lymphoid follicles is also a typical finding(ll). When 
neutrophils are present, the chronic gastritis is said to be 'active', i.e. chronic L
active gastritis.
In this thesis, the term of chronic gastritis refers to H. pylori-associated chronic 
gastritis, unless otherwise stated. 3
Auto-immune chronic gastritis 
This type of gastritis is associated with the presence of circulating auto- s
antibodies, nearly always to the parietal cells(present in 80-90% cases) in the 
gastric glands, and often to intrinsic factor also(blocking type 70%, binding type
■f
30%). The histological features are the loss (‘atrophy’) of the specialised glands
in the deeper zone of the body mucosa(so-called atrophic gastritis),
accompanied by a mixed chronic inflammatory cell infiltrate. It is seen ;l
%classically in pernicious anaemia, where defective secretion of intrinsic factor 
leads to vitamin B,2 deficiency. Almost invariably there is also hypochlorhydria.
Patients with advanced autoimmune gastritis or pernicious anaemia are less |
often colonised with 77. pylori than is seen in the general population(12,13). It is 
assumed that advanced autoimmune gastritis presents an unfavourable 
environment to H. pylori.
Reflux (chemical) chronic gastritis
The type of chronic gastritis due to persistent reflux of duodenal contents into 
the stomach. It has a characteristic histological appearance of foveolar 
hyperplasia, oedema and vasodilation in the lamina propria(14). Inflammatory
20 S
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cells are scanty, in contrast to H. /jy/on-associated gastritis. This lesion is seen 
classically in gastric biopsies from post-gastrectomy patients, in whom 
duodenal-gastric reflux is common. It is now generally accepted that this type of 
gastritis is caused by the damaging effects of bile acid, lysolecithin and 
pancreatic enzymes. Similar lesions can be seen in patients receiving long-term 
non-steroidal anti-inflammatory drugs, suggesting that this type of gastritis 
represents a reaction of the gastric mucosa to chronic chemical irritation.
Chronic lymphocytic gastritis
This is a newly recognised variant of chronic gastritis, characterised by marked 
infiltration of the surface and foveolar epithelium by mature T-lymphocytes(15- 
17). The aetiology is unknown, but the lymphocytic infiltrate has been linked to 
that in the small bowel in coeliac disease. Because of the distinctive endoscopic 
appearances with nodules bearing a central erosion, it has been termed chronic 
erosive gastritis or 'varioliform' gastritis. These varioliform lesions are usually 
found in the corpus alone or corpus and antrum. Similar lesions may occur in 
the antrum in H. pylori -associated chronic gastritis and reflux gastritis.
Eosinophilic gastritis
This is a rare condition characterised by a dense infiltration of eosinophil 
leukocytes into the gastric mucosa(18). Peripheral blood eosinophilia and raised %serum IgE levels are often present. It is thought to be basically an allergic
'
disorder.
CI ra n ulorn a to us gastritis
i
This is an uncommon type of gastritis with granulomatous inflammation in the 
gastric mucosa. It is recognised in sarcoidosis, tuberculosis and Crohn's disease.
21
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1.2.3 Helicobacter pylori-associated chronic gastritis
Epidemiology
This type of chronic gastritis is common in patients with dyspepsia referred for 
endoscopy(19-21). The frequency increases with age(22,23) in parallel with the 
age-related increase in the prevalence of H. pylori infection. There are 
geographical variations in the incidence of chronic gastritis(23-26).
Natural history
Siurala et al(27-29) demonstrated that chronic gastritis with a variable degree of 
activity is a dynamic but slowly evolving process, progressing over a period of 
18 years to gastritis with mild atrophy and the latter may progress to severe 
atrophy after many years. There may be a small number of patients with chronic 
gastritis who improve over time(30), but in most patients, it is usually a 
progressive process, leading to a variable degree of glandular atrophy.
Pathogenesis
Results from pathological studies and volunteer studies confirm the association 
between H. pylori and chronic gastritis(4,31), although the exact mechanism by 
which H. pylori causes gastritis is not fully established. The bacteria do not 
seem to invade the gastric mucosa. On close examination of biopsy specimens 
from patients with H. pylori-relaied gastritis, the inflammatory events are deep 
in the tissue, away from the area of colonisation. One theory is that the 
organism sheds large amounts of soluble products which diffuse into the 
mucosa, against which the inflammatory and possibly a local immune response 
are directed(32-34). Urease has been proposed as one of these products. H. 
pylori urease has been shown to be present deep in the gastric mucosa and the
22
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1.3.2 Gastric secretion
Gastric acid
A
protein is known to be imiminogenic(35). The presence of neutrophils in the 
mucosa could either be a direct consequence of some bacterial products which 
are chemotactic or be the result from other immune activities occurring 
concurrently in the mucosa, such as the production of pro-inflammatory 
cytokines(36-38). Accumulation of chronic inflammatory cells(i.e. lymphocytes, 
plasma cells and macrophages) is thought to be the result of an immune A
response to bacterial antigens.
1.3 Peptic ulcer
1.3.1 Aetiology
The aetiology of peptic ulceration is still poorly understood. It has been 
considered to be multifactorial, involving environmental and genetic factors and 
has been generally accepted as a consequence of an imbalance between 
aggressive factors and mucosal defence mechanisms. Aggressive factors include 
gastric acid, pepsin, H. pylori infection, bile acids, NSAIDs and alcohol.
Mucosal defence factors comprise mucus, bicarbonate, epithelial cells, mucosal f
blood flow and prostaglandins. The fact that most patients with duodenal ulcer 
are colonised with H. pylori and had higher gastric acid output suggested that 
these two factors are important in the aetiology of duodenal ulceration. In 
patients with gastric ulcers, gastric acid secretion is not increased, suggesting 
factors other than acid secretion, such as NSAID use, H. pylori and a weakened 
mucosal barrier are involved. The following section reviews the major factors
contributing to peptic ulcer formation and their relationship to H. pylori.
23 I
Hydrochloric acid is produced by parietal cells which are mainly distributed in 
the body of the stomach. The numbers of parietal cells vary from person to
All stimulatory mechanisms finally activate this pump(3 9). Stimulators of acid 
secretion include histamine, gastrin and acetylcholine. Histamine stimulates 
acid through Hg receptors on the parietal cell. Gastrin may stimulate acid
followed by a complete resolution of the hypergastrinaemia(50-52).
1
person. The physiological functions of gastric acid include inactivation of ÿ
+ s,microorganisms and activation of pepsinogen. Hydrogen(H ) ions are actively I
secreted by an H’^ /K’^ ATPase on the canalicular membranes of the parietal cell. "'f
secretion by releasing histamine through gastrin receptors on mast cells(40-41). 
Acetylcholine also stimulates secretion through cholinergic receptors both on 
mast cells and parietal cells. The presence of gastric acid has been considered to 
be essential for the development of duodenal ulcer.
Gastrin
Gastrin is produced by G cells in the antrum. It stimulates acid secretion and has 
a trophic effect on mucosal cells. A negative feedback mechanism stimulates 
secretion when pH rises and inhibits secretion with antral acidification. 
Somatostatin may be important in the control of gastrin secretion(42, 43). y
. y
Protein in food and gastric distension stimulates gastrin release(44). H. pylori 
infection, both in normal healthy subjects and in patients with duodenal ulcer, is 
associated with hypergastrinaemia. When compared with H. /py/orz-negative
healthy subjects, H. jpp/ori-positive individuals have a modest elevation of
serum gastrin in the fasting state and a quite substantial elevation after a meal or Istimulation with gastrin releasing peptide(GRP)(45-49). Eradication H. pylori is
Hypergastrinemia in Zollinger-Ellison syndrome patients results in high rate of g
secretion of gastric acid and pepsin, which overwhelms the mucosal protective 
factors, resulting in peptic ulceration.
'ISomatostatin |
Somatostatin secreted from antral D cells is the main inhibitor of exocrine and g
endocrine secretion by the stomach. D cells in the gastric antrum are stimulated
yby luminal acid to release somatostatin which then inhibits adjacent G
■'icells(42,43) and therefore inhibits acid secretion. It was found that antral g
somatostatin concentrations and D-cell density are significantly lower in H. A
,pylori-^VQ patients with duodenal ulcer than in H. pylori-\Q  subjects(53-56).
After eradication, antral somatostatin levels and D cell density return to the
normal range, suggesting that the hypergastrinaemia found in H. j^y/on-positive
1patients with duodenal ulcer is due to a deficiency of antral D-cell somatostatin.
which normally inhibits the synthesis and release of gastrin(57).
Pepsinogens
These proenzymes are produced in chief cells and mucus cells, and are 
converted to the active pepsin, in the presence of acid and by pepsin-induced 
autoactivation. There are two major groups of pepsinogens(58). Type I
;
pepsinogens are secreted by the chief cells in the body mucosa and are encoded 
on chromosome II. It can be detected in blood which correlates moderately well 
with acid output(59). Type II pepsinogens are also secreted from mucus glands
..-■4in the antrum, duodenum and cardia in addition to the chief cells. Pepsinogen A
may be under the same control as gastric acid; histamine and gastrin stimulate A
pepsinogen secretion(60). Î:
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IEffect o f H. pylori on gastric secretion
A  complicated relationship may exist between H. pylori and gastric acid 
secretion. In some patients, such as those with duodenal ulcer, H. pylori 
increases acid secretion , possibly by a decrease in the expression of gastric 
mucosal somatostatin and the subsequent increase in gastrin release(57). The 
lack of somatostatin probably explains why acid secretion is not inhibited 
properly during fasting and when the gastric pH is low. This may contribute to 
duodenal ulcer formation.
H. pylori has also been linked with decreased acid secretion during primary 
infection(61) and also in the long term by producing atrophy(62). H. pylori- 
related decreases in acid secretion in some patients have been postulated to 
increase the risk of gastric cancer by allowing bacteria which produce 
carcinogens to persist in the gastric lumen(63).
It is unclear as to why H. pylori increases acid secretion in some patients, while 
in other patients it decreases acid secretion and causes atrophy.
I.3.3 Mucosal defence
Mucus-bicarbonate barrier
Gastric mucus consists of glycoproteins which associate by hydrogen binding to
form an adherent lubricating gel over the surface epithelium(64). Mucus is
secreted by surface epithelial cells, which acts as a partial barrier to diffusion of
small molecules such as acid, and a more effective barrier to macromolecules
and bacteria. The surface epithelial cells also secrete sodium bicarbonate,
which, together with mucus can maintain a epithelial cell surface pH of 7 in the
,face of a luminal pH of 2(65,66). This barrier could be dissipated by certain
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agents such as aspirin or bile acids. There have been limited studies in vitro 
suggesting that H. pylori can degrade mucus(67,68); it has been shown that the 
mucus layer in infected patients was thinner than that found in uninfected 
persons(69).
Surface epithelial cell barrier
An intact epithelial cell layer is thought to be important in mucosal defence and 
it has been suggested that this barrier is formed by the hydrophobic membrane 
of the epithelial cells, made of waxy phospholipids(70). It was shown that the 
hydrophobicity of isolated gastric biopsies is altered in H. pylori infected 
patients (71,7 2).
Mucosal blood flow
Blood flow is important for maintainance of mucosal pH by clearance of back- 
diffusing acid. Vasoconstriction predisposes the mucosa to injury induced by 
bile and other agents(73).
Prostaglandins
Inhibition of prostaglandin synthesis is considered to be the main mechanism of 
NSAID-related peptic ulcer. Prostaglandins protect gastroduodenal mucosa 
probably by maintaining mucosal blood flow(73); by increasing serosal to 
mucosal water flux(74), which may protect mucosa by dilution of mucosal 
concentration of noxious substances; and by providing direct protection of 
isolated gastric glands and epithelial cells against ethanol or NSAIDs(75). There 
is little data on the relationship between H. pylori infection and mucosal levels 
of prostaglandins.
1.3.4 Gastric metaplasia and duodenitis
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Gastric metaplasia is a term applied to the presence of gastric-type mucus- 
secreting cells in the surface epithelium of the duodenum. It is thought that the 
metaplastic cells originate from the Brunner’s g lands (76). Gastric metaplasia is f
distributed in a patchy manner in the duodenum, but is maximum in the first
part(77,78). The incidence of gastric metaplasia increases with age(77). It is 
more common in men than in women, but this difference can be attributed to 
higher acid output in males(77). Gastric metaplasia is a non-specific response to 
injury and inflammation, and may be seen in Crohn’s disease of the 
duodenum(79). The most common cause is excess acid reaching the first part of I
the duodenum. This has been proven in animal experiments with induced 
hyperchlorhydria(80-83) and by the correlation between the presence and extent ;|
of the metaplasia and maximal acid output in human subjects(84). Some studies 3%
suggest that H. pylori infection may also contribute to the extent of gastric f
metaplasia by inducing an increase in gastric acid output(85,86).
Active duodenitis is now accepted to be a precursor of duodenal ulceration(87).
It has been suggested that there is an association between gastric metaplasia of 
the duodenum, H. pylori infection in the metaplastic area and the subsequent 
development of active chronic inflammation in the duodenum, i.e.
duodenitis(88). In this hypothesis, acid-induced gastric metaplasia and H. pylori 1
■ 3;'7infection are essential prerequisites for the development for duodenitis, which 
may lead to duodenal ulceration.
t1.3.4 Role o f  H. pylori
■ I 
%Unequivocal evidence, especially that in which eradication of the bacterium 
leads to the cure of ulcers(89), supports the concept that H. pylori is an
important pathogenic factor in peptic ulceration, although the mechanisms by 
which H. pylori predisposes to ulcer formation are still not fully understood. 
Only a small number of infected patients develop peptic ulcer, despite a 
substantial number of people in the general population who are infected with the 
bacterium. The current understanding is that both bacterial virulence factors of
H. pylori and host response are important in the pathogenesis of peptic ulcer. 
Virulence factors ofH . pylori
H. pylori cytotoxin and CagA protein(cytotoxin-associated protein) are two 
virulence products linked to peptic ulcer, especially duodenal ulcer. Although 
the H. pylori genome shows great diversity(90), the majority of strains can be 
grouped into two types. Type I strains possess cytotoxin(encoded by vac A 
gene) and expressing cytotoxin-associated protein(encoded by cagA gene), and 
are more frequently found in patients with peptic ulcer. Type II strains do not 
express these proteins and are less frequently found in peptic ulcer patients(91-
duodenal ulcer formation, although the determinants for H. pylori density is
"I
93).
It has also been suggested that higher antral bacterial density is important in 
unclear(94).
Another hypothesis regarding the development of duodenal ulceration is that y
gastric metaplasia in the duodenum, in response to higher acid output, precedes 1H. pylori colonisation in the metaplastic area; duodenitis develops and
Jieventually leads to ulcer formation(88,95). IHost factors 3.
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There are many more people infected with the putative ulcerogenic strains of H. 
pylori than the number of people with ulcers. Some genetic component(s) of the 
host’s inflammatory-immune response to H. pylori, possibly in concert with an 
environmental factor(s) may also be important in the development of peptic
7
ulcer disease. In animal studies, large variations in the severity of disease were 
observed after infection of different inbred strains and congenic mice with a 
single isolate of H. felis, suggesting that the difference in host response may Iaffect the disease outcome following Helicobacter infection(96). However, little y
.is known about the human genetic basis for the apparent differences in clinical 
outcomes.
1.4 Helicobacter pylori
7.4.1 Introduction
H. pylori, once known as Campylobacter pylori, was first isolated in 1983 by 
Marshall and Warren(l,2). It is a Gram-negative microaerophilie spiral 
bacterium that resides in the stomachs of human and other primates. Recent 
studies have established associations between H. pylori infection and chronic 
gastritis and peptic ulcer disease(3-7). H. pylori infection has also been linked
3iwith an increased risk for the development of mucosa-associated lymphoid y
tissue(MALT) lymphoma(97-100) and possibly gastric carcinoma( 101-104).
1.4.2 Epidemiology
Prevalence
Serological studies have shown that the prevalence of H. pylori infection 
increases with age(105-l 10), although some data suggests that the infection is 
acquired primarily in childhood and the incidence is higher in younger
30
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children(lll-113). Lower socio-economic status has been found to be 
associated with a higher prevalence of H. pylori infection(l 10,114-118). H. 
pylori infection is more common in dyspeptic patients. The prevalences have 
been reported as 45-87% in non-ulcer dyspepsia patients(l 19-123), 90-100% in 3duodenal ulcer patients (124,125) and 60-100% in those with gastric ulcers(126- %
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Source and mode o f transmission 3;
Both the source of H. pylori infection and the mode of transmission are largely 
unknown. H. pylori is generally considered to be a human pathogen, but the y
isolation of H. pylori from macaques suggest that non-human reservoirs may ;l
'I
exist, although it is not known if this species provides an important reservoir for 
human infection(129-130). The isolation of viable H. pylori in saliva and gastric 
juice of domestic cats implies that transmission from cats to humans is i
possible(131). The detection of 77. pylori in dental plaque(132), saliva(133), bile f
samples(134) and faeces(135-136) by PCR or/and culture would support an oral- 
oral or faecal-oral mode of transmission. Although the exact mode of person-to- 
person transmission is unknown, some studies have suggested that some 
occupational groups may be at greater risk of acquiring H. pylori infection e.g 
endoscopists(137); adequate disinfection and cleaning of endoscopes appears to 
eliminate the risk of transmission( 138).
1.43  Diagnosis o f  infection
Since the isolation of H. pylori in 1983, a wide range of techniques has been 
established for the diagnosis of H. pylori infection. Although isolation and
7-identification of the organism in endoscopic biopsies remains the ‘gold y
I
standard’, some indirect methods, such as the urea breath test, allow the 
detection of H. pylori to be made without subjecting patients to endoscopy. 
Tests based on antibody detection in serum is also a non-invasive technique; 
these have played an important role in epidemiological studies.
Methods of detection of H. pylori can be categorised as endoscopy based 
tests(or invasive tests) and non-invasive techniques.
Invasive tests include histology, bacterial culture, biopsy urease testing, and 
some molecular techniques such PCR and DNA hybridisation. Non-invasive 
methods include urea breath tests and serological tests.
Invasive methods 
Histology
Direct visualisation under the microscope of H. pylori in endoscopic biopsies by
various staining methods provides reliable and sensitive detection of the
.organism. The Warthin-Starry silver stain was recommended initially, because it
is sensitive and very good for visualisation of the bacterium(139). However, the
method is relatively complicated and time-consuming. The conventional
haematoxylin and eosin stain is very well suited for assessing and grading
inflammation, but less reliable for detecting H. pylori, because the organism is
_less easily distinguishable with this stain. Giemsa stain is considered to be a
: ; ■
good choice, because of its simplicity, speed and low cost(139). Cresyl fast 
violet staining has also been used and proven to be convenient and
reliable(140). Immunohistochemical( 141-142) and immuno fluorés ent
methods(143) have also been regarded as reliable for detection of H. pylori in
I
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fresh biopsies, frozen sections or in formalin-fixed tissue. However, these 
techniques are relatively more complicated and more expensive.
Culture o f H. pylori
Isolation and characterisation of the organism is the “gold standard” for 
identification of H. pylori, although it needs some special equipment and is 
relatively time-consuming. Isolation of H. pylori by culture is particularly 
valuable for typing the organism and for determining its sensitivity to 
antibacterial agents. It is also important for investigating the virulence factors of
H. pylori including several antigens used for the production of serological 
assays and possible vaccines.
Biopsy urease testing
A very simple way of detecting H. pylori is to place the endoscopic biopsy 
specimen into a urea-containing medium, and based on the organism’s ability to 
produce large amounts of urease, a distinctive colour change usually can be seen 
within hours. It is both sensitive and specific(144-146).
Molecular techniques
These methods include PCR tests and DNA hybridisation, using H. pylori 
specific primers and DNA probes. They are very sensitive and fairly 
specific(147,148). PCR allows the in vitro production of large amounts of 
specific DNA. Application of PCR technique to H. pylori research has not only 
provided a new approach to diagnosis of H. pylori infection, but also allowed 
the detection of specific genes such as cagA, fingerprinting of individual strains, 
cloning and sequencing of important genes(149).
Non-invasive methods
;7i
I
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Urea breath tests
In an infected patient, H. pylori urease hydrolyses urea, labelled with or 
to release labelled COg, which is exhaled and can be detected. The urea breath 
testing methods are both sensitive and specific for active H. pylori infection 
(150), which is especially useful in assessing the efficacy of eradication 
therapy(151).
Serological tests
Based on the systemic immune response elicited by H. pylori infection, various 
serological tests have been developed to detect specific antibodies to the 
bacterium. The IgG isotype has been used more widely and more reliable than 
IgA(152). In general, enzyme-linked immunosorbent assay(ELISA) is 
considered to be more sensitive than other techniques such as agglutination and 
complement fixation(I53). Most of the current commercial ELISA kits using 
partially purified antigens containing urease, give a fairly high sensitivity and 
specificity( 154,155). However, comparisons are sometimes difficult between 
different studies and the cut-off values are difficult to standardise for different 
populations(l 56,157). It is less reliable in diagnosing active infection, because 
the presence of antibody may indicate a past exposure to the organism. It is 
more useful in epidemiological studies and may be useful in monitoring the 
long-term effect of treatment. Several studies have shown that after eradication, y
serum IgG and IgA antibodies gradually fall within six months(158).
1.4.4 Treatment o fH . pylori infection
It is accepted that patients with duodenal ulcer and gastric ulcer with H. pylori 
infection should be treated with eradication therapy(159,I60). The combination
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of an antisecretory drug, usually a proton pump inhibitor, with two antibiotics 
has been accepted as an highly effective regimen for H. pylori eradication. The 
most commonly used regimens include one proton pump inhibitor(either 
omeprazole or lansoprazole), and two antibiotics from among clarithromycin, a 
nitroimidazole(metronidazole or tinidazole) and amoxycillin. The new short­
term and low dose triple therapy regimen has been proven to be as effective as a 
longer one, with better compliance, fewer side effects and lower cost(161,162).
1.4.5 Virulence factors ofH . pylori
H. pylori produces several enzymes and exotoxins, which have been suggested 
as being important in inducing gastroduodenal mucosal damage. Colonisation of
H. pylori in the gastric mucosa is accepted as a prime determinant of 
pathogenicity, considering that the acidic gastric environment is hostile to most 
microbial species. Several factors have been suggested to be important in 
helping colonisation of H. pylori including the urease and various adhesins. 
Urease
Urease is an highly active enzyme with a molecular mass of 600Ka and is 
composed of two subunits, UreA(26.5KD) and UreB(60.3KD)(163,164). The 
native protein enzyme consists of six copies each of UreA and UreB.
Studies have also established the important role of urease in the pathogenesis of
H. pylori. Production of the enzyme is essential for successful colonisation of 
the gastric mucosa(165) and triggers a strong serum immune response(166,167). 
All the gastric Helicobacter species isolated so far have a similar urease 
enzyme, suggesting that it is important in colonisation(168-170). Direct 
evidence has been provided by an animal study in which a urease-negative
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variant of H. pylori failed to colonise gastric mucosa in gnotobiotic pigs(165). 
The urease helps H. pylori to survive in gastric acid by production of ammonia 
leading to its penetration of the mucus surface and colonisation within an 
alkaline environment( 171).
In addition to its beneficial effect on survival, urease itself could cause direct 
tissue damage. Some studies have suggested that ammonium hydroxide, 
generated by urea hydrolysis, contributes significantly to histological 
damage(172-174). Urease activity may also cause tissue damage through 
interaction with the immune system. Studies have suggested that urease can act 
as chemotactic factor and activator for monocytes and neutrophils, resulting in
I
y
the release of inflammatory cytokines and reactive oxygen metabolites to cause s.
mucosal injury( 175,176).
Adhesins and/or receptors.
The findings that H. pylori has a very specific association with gastric-type 
epithelium suggests the presence of adhesin molecule(s) and/or specific
receptor(s) on gastric mucosal cells. Several potential adhesins and receptors 
have been identified, including haemagglutinins, urease and flagellin on the Ibacterium and laminin on the gastric cell(177). Studies have also suggested that
the Lewis b blood group antigen is a H. pylori receptor on the gastric
surface(178“l 80).
Phospholipases
Phospholipase A2 and C are invariably detected in strains of H. pylori 
(181,182). Because the phospholipids are important components in the gastric 
mucosal defence, the degradation of these components by phospholipases could
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Superoxide(02') is destroyed by SOD as shown in the following reaction:
VIVO.
damage mucosal integrity(183). It has also been suggested that H. pylori 
phospholipases can disrupt the normal phospholipid bilayer of the epithelial cell 
membrane and liberate arachidonic acid, which is then converted to leukotrienes 
and other eicosanoids(184). These compounds may change membrane 
permeability and mucus discharge.
Catalase
Catalase acts on hydrogen peroxide to form water and oxygen.
catalase
2 H2O2 ....................> 2 H2O + Gy
H. pylori has very high catalase activity, 3-10-fold higher than that of most
other bacteria. This could be related to adaptation of the enzyme to an 
.environment rich in toxic oxygen metabolites(185). So it could be considered to 
be a virulence factor which may protect the bacterium from the damaging 
effects of reactive oxygen metabolites produced by phagocytes(l 86-188). 
Superoxide dis mutas e(fOT))
SOD
2 O2 + 2 H  > H2O2 + O2
Like catalase, SOD is also involved in catalyzing the breakdown of super oxide
radicals. So it may also protect the bacterium against killing by neutrophils in
Cytotoxin and CagA protein
The vacuolating cytotoxin is one of the first toxic products identified from H. 
pylori. The toxin is excreted into the culture medium and has been shown to
. '4>
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cause vacuolation in several cultured cell lines. It was shown that cytotoxic 
strains were more frequently found in patients with duodenal ulcer than in 
patients with chronic gastritis alone(189).
CagA is another highly immunogenic product of H. pylori, which was shown to 
be linked with peptic ulceration and its expression is closely associated with 
cytotoxin production(91-93).
1.4.6 H. pylori cvtotoxin and CagA protein
Leunk et al first described the cytotoxic effect of H. pylori and found activity in 
about 50% of the strains from different parts of the world(190). Broth culture 
supernatants of the bacterium induced a non-lethal vacuolating effect on tissue 
culture cell lines including Vero cell and HeLa cells. Figura et al(189) found 
that cytotxic strains were more frequently found in patients with peptic 
ulceration than those with chronic gastritis alone and suggested that 
cytotoxinogenic strains were associated with serious gastroduodenal disease 
more often than non-toxinogenic strains. This finding was later supported by 
others(19I,192). In addition, toxinogenic strains were more frequently found in 
areas where there was a high prevalence of gastric atrophy and gastric 
cancer(193-195). Therefore testing strains of H. pylori for toxinogenicity may 
be helpful in determining the risk of developing peptic ulcer and gastric 
malignancy in different populations and in determining which group of infected 
patients should be treated.
Nature o f toxin
Cover and Blaser(196) have shown that the native cytotoxin of H. pylori is a 
protein aggregate with a molecular weight >970kDa. Sodium dodecyl sulfate-
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polyacrylamide gel electrophoresis(SDS-PAGE) analysis showed that the 
protein is composed of subunits of 87kDa. The gene expressing the toxin was 
designated vacA. Studies have shown that the vacA gene was present in all 
strains of H. y>y/or/( 197-200) including cytotoxin-negative strains; however, the 
gene does not express cytotoxin in these strains. It was shown that in certain 
regions of the gene, there is substantial diversity(201,202). In the highly diverse 
middle region, sequences from cytotoxic strains form a family in which the 
sequences are highly related(90%) to one another. The non-cytotoxic strains 
form another highly related family(>90% identity in the middle 
region)(l97,201). It was shown that the vacA genes are a mosaic, consisting of 
any one of three signal sequences(sla, sib, s2) and one of two middle-region 
alleles(ml, m2). In total, any H. pylori strain could have one of six possible 
genotypes; vacA genotype correlated well with cytotoxin phenotype. It was 
shown that s l/m l genotypes were high cytotoxin-producers; s2m2 type strains 
were non-toxin producers(201).
Activity o f toxin
Studies have shown that the toxin induces intracytoplasmic vacuole formation in 
cultured cell lines(190). Vacuoles are first visible around nuclei and become 
larger and confluent, and finally break up resulting in cell death. Ammonia and 
nicotine, which can cause cell vacuolation on their own, could potentiate the 
vacuolating activity of the toxin in vitro(203,204). This could possibly account 
for a higher prevalence of duodenal ulcer in patients who smoke.
The mechanism of vacuolation has been recently clarified by Papini et al(205), 
who demonstrated that the toxin stimulates a cellular proton pump. There are
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many different ATPases at the level of the membrane and intracellular 
compartments. The target of the toxin is a vacuolar-type adenosine 
triphosphatase(ATPase) of the endocytic compartment. As a result of this 
stimulation, a transmembrane pH gradient is formed. Basic substances, always 
present in the environment, cross endocytic membranes and are protonated as 
they encounter an acidic environment; once protonated they remain inside since 
the membranes are not permeable to protonated substances, and attract water 
osmotically which causes swelling.
It has been shown that the vacA genotype is associated with the likelihood of 
having peptic ulceration; s im l type strains were more frequently found in 
patients with peptic ulceration or a past ulcer history, whereas s2/m2 genotype 
were much less often associated with peptic ulceration(206).
Extracts of VacA+ cytotoxic strains were shown to inhibit gastric cell 
proliferation in vitro by preventing epidermal growth factor from binding to its 
receptor on cultured cells(207). It was suggested that cytotoxic strains may 
interfere with the healing process of erosive and ulcerative lesions in vivo(208). 
CagA protein
Further evidence in support of cytotoxic strains being more pathogenic comes 
from studies of the immune response to a 120-140kDa protein which is closely 
associated with the expression of cytotoxin and has been termed the cytotoxin-
with CagA positive strains induces a high level of anti-CagA antibodies, both
h
associated protein(CagA). The CagA protein is highly immunogenic; infection
I
.1locally and systemically. Cover et al(209) first reported that all duodenal ulcer #
patients studied had serum IgG antibodies to a 128KD protein and only about
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60% of patients with gastritis alone had antibodies to this protein. Crabtree et
,al(210) showed that gastric mucosal IgA responses to a 120KD protein was f|
associated with peptic ulceration. It was found that about 40-60% of patients 
with gastritis alone were infected with CagA+ve strains compared to 80-100% i
Î
of those with duodenal ulcer(209-211). In patients with gastric ulcer, the results 37
were intermediate(209,211). It was also shown that infection with CagA+ve 
strains of H. pylori was associated with a increased risk of development of 
atrophic gastritis and gastric adenocarcinoma (212,213).
The cagA gene
The gene encoding the CagA protein was cloned and designated cagA in 
1993(91,92). Unlike the vacA gene, the cagA gene is not present in all strains of
H. pylori. The cagA gene is only present in strains expressing the CagA protein. I
One feature of the gene is the presence of repeated patterns. The difference in ■I'number of repeats could explain the size range of the CagA protein from 120- 7+
140KD(91).
It was shown that cagA+ve strains were associated with more severe gastric Iinflammation and epithelial injury compared to cagA-ve strains(210). Studies in ç
vitro also showed that cagA+ve strains induced higher levels of interleukin- 
8(IL-8), a potent proinflammatory cytokine, than cagA-ve strains(214).
Relationship between VacA and CagA
It was shown that in about 70% strains of H. pylori, the expression of 
cytotoxin(VacA) are correlated with the possession of cagA gene(215). In a A
genetic study, cagA status was found to be concordant with the vacA genotype I
3 
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in most strains studied. All s2(vacA genotype) strains were cagA-ve and all 
cagA+strains were si (vacA genotype)(201).
1.5 Host responses to H. pylori
H. pylori infection induces significant local and systemic immune responses, as 
shown by infiltration of neutrophils, specific T-and B-cell responses, local 
production of proinflammatory and immunoregulatory cytokines, and both local 
and systemic antibodies to H. pylori. Recent studies have suggested that there 
are strain to strain variations in the induction of mucosal inflammatory 
responses(216).
I.5.1 Neutrophils
Morphological and structural characteristics
Neutrophils contain two major granule populations, primary or azurophil 
granules and specific or secondary granules(217). Primary granules contain acid 
hydrolyses, neutral proteases, myeloperoxidase, cationic proteins and lysozyme. 
The main function of primary granules is microbial killing and digestion. 
Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein 
and cytochrome b, and their membranes serve as a source of receptors.
As part of the host’s system of defence against infection by pathogenic 
microorganisms, the roles of neutrophils are to seek out, ingest and kill the 
invading organisms. These processes involve chemotaxis, phagocytosis, 
degranulation, the neutrophil oxidative burst, and bacterial killing.
Chemotaxis
Chemotaxis is a process in which neutrophils receive signals from invading 
organisms or injured or dead tissue and move towards the area from which the
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signal emanates. The process involves many protein molecules and 
inflammatory mediators including intercellular adhesion molecules(ICAM), 
bacterial chemoattractants and cytokines(218-220).
Phagocytosis
Phagocytosis is a process by which bacteria are ingested and killed by white 
blood cells such as neutrophils and macrophages. This is one of the major 
defence mechanisms by which the immune system protects man against 
bacterial infection.
It is a two step process involving attachment and engulfment of the phagocytic 
particle. Some microorganisms and inert particles may be ingested by 
neutrophils in the absence of serum factors but most bacteria must be coated 
with opsonins for attachment to neutrophils to occur. Specific IgG and 
complement are the major opsonic factors promoting recognition and ingestion 
of microorganisms by neutrophils.
Once the phagocytes have arrived at the focus of bacterial infection and come 
into contact with the bacterium through specific receptors, engulfment of the 
bacterium takes place as a result of fusion of pseudopodia which project from 
the plasma membrane of the phagocyte. The pseudopodia engulf the bacterium 
to form a vesicle called phagosome, which then buds off from the plasma 
membrane and lies within the cytoplasm of the neutrophils or macrophages. 
Once the phagosome has formed, lysosomes moves towards to it and fuse to 
form the phagolysosome. The lysosomal granules disappear as ‘degranulation’ 
occurs.
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Degranulation
-
Degranulatioii is initiated before completion of ingestion. Ninety percent of the 
contents released from specific granules during phagocytosis can be found 
outside the cell. These granules appear to function principally as secretory 
granules. More than 50% of the contents released from primary granules during 
phagocytosis can be recovered from the phagosome(221). These enzymes 
function best at the low pH(6.0-6.5) found in phagosomes. Consequently, the 
contents of the primary granule appear to function principally in microbial 
killing and digestion.
iOxidative burst
The process of phagocytosis is associated with a burst of metabolic activity —  
the respiratory burst, which results essentially in the stepwise reduction of 
molecular oxygen to hydrogen peroxide. This respiratory burst is associated 
with a 2- to 20-fold increase in oxygen consumption compared to a resting cell 
and a considerable increase in glucose metabolism via the hexose 
monophosphate shunt.
The basic series of reactions of the respiratory burst results in (1) oxygen 
consumption, (2) superoxide production, (3) hydrogen peroxide production, and
I
(4) stimulation of the hexose monophosphate shunt. The oxidative burst process
.s
is illustrated in Fig 1.
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Microbicidal mechanisms
The above postphagoeytic events are designed to deliver the products of 
degranulation and the respiratory burst to the phagocytic vacuole. The 
phagosome plays an important role in this process because it provides a closed 
space in which an ingested microbe is exposed to high concentrations of toxic 
substances and the exposure of the phagocyte and other cells to these 
metabolites is minimised(222).
Oxygen dependent bactericidal mechanisms can be divided into imyeloperoxidase-dependent and -independent reactions(223). The essential
■requirements for the myeloperoxidase-dependent mechanisms include 
myeloperoxidase, released from the primary granule; hydrogen peroxide, from 
the oxidative burst. Hydrogen peroxide has a bactericidal effect itself, but in the 
presence of myeloperoxidase, the potency is enhanced by 50-fold. Other oxygen 
metabolites including superoxide, singlet oxygen, hydroxyl radical and 
hypo chlorous acid are also considered to have microbicidal properties(223~225). j|IThe oxygen-independent microbieidal mechanisms include lactoferrin, ilysozyme, and cationic proteins. The enzymes released from the granules are .'3
important in the killing and digestion of ingested microorganisms(225,226).
Tissue injury associated with neutrophil function 
Ordinarily, degranulation and the oxidative burst are restricted to the points of 
contact between the organism and the phagolysosome(227,228). There are Ireceptor-mediated mechanisms to downregulate the oxidative process during i
continuous exposure to homologous stimuli(229) and to products of the 
oxidative burst(230). Oxidative inactivation of inflammatory
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mediators(231,232), and the oxidase itself would further limit neutrophil 
activation and confine the toxic effects to the vicinity of the organism.
However, the toxic substance of these microbicidal systems can be released and 
cause damage to host tissues in certain diseases associated with auto antibody 
formation, immune complex deposition, excessive release of inflammatory 
mediators, and chronic low-grade inflammation(233,234).
1.5.2 H. pylori and neutrophil function
H. pylori infection is associated with active chronic gastritis, which is Icharacterised by a prominent infiltration of neutrophils and mononuclear cells. ■7«.
Studies have shown that H. pylori secretes chemotactic factors, which might 
account for the considerable inflammatory response in gastric mucosa. Craig et 1Ial(235) reported that H. pylori supernatant showed chemotactic activity for 3
neutrophils, attracting about 50% of the cell activity seen with formyl- 
methionyl-leucyl-phenylalanine(FMLP); monocytes were attracted with about 
90% of the activity observed with FMLP. The chemotaxin was considered to be 
a protein(s) because it could be destroyed by proteinase(236,237). Interleukin 8 i;
released from gastric mucosa in response to H. pylori infection may also
Ïcontribute to the accumulation of inflammatory cells(216).
There is also evidence that H. pylori can activate neutrophils to produce a
respiratory burst. Nogaard et al(236) showed that H. pylori could cause f
neutrophil degranulation releasing myeloperoxidase, which is a crucial
component in oxygen dependent microbial killing. Several studies using 
, ,chemiluminescence have also demonstrated that H. pylori could activate 
neutrophils to produce reactive oxygen metabolites(237). The neutrophil
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activating property has been suggested to be a protein(s)(236). Mai et al(175) 
showed that soluble surface proteins from H. pylori activate 
monocytes/macrophages through a lipopolysaccharide(LPS)-independent as well 
as a LPS-dependent mechanism. It was shown that soluble surface proteins, 
which are rich in urease and do not contain LPS, stimulate monocytes to 
express HLA-DR and IL-2 receptor and to produce IL-1 and TNF. It was also
shown both of these preparations induced monocyte production of
"7superoxide(02').
1.5.3 Reactive oxygen metaholitesIROM) 3:.7Source o f ROM
There are two possible sources of ROM production in amounts of pathological
pimportance(238)(Fig 1): activated phagocytes (particularly neutrophils) and 
.xanthine oxidase, formed from xanthine dehydrogenase during tissue ischemia |
and catalysing the formation of super oxide during reperfusion. The neutrophil 
membrane contains an NADPH-dependent oxidase system that is a highly 
efficient source of superoxide radical generation. The enzyme is normally 
dormant, but after phagocytosis occurs, the oxidase becomes active, resulting in 
the production of superoxide. The superoxide is the precursor of hydrogen
•ftperoxide, which gives rise to hypochlorous acid in the presence of chloride ions If
and myeloperoxidase.
Mechanisms o f damage due to oxidative stress 7
ft:ROM production during the inflammatory response is an important host defence
l i ;
mechanism against certain micro-organisms, but it is not always confined within 
the phagocytic cells(239). When produced in excess, ROM could be released to
:.ft:
i
the outside of the cell, from whence they can attack extracellular targets, 
causing cell/tissue damage(239,240). The mechanisms by which ROM induce 
cell injury include protein degradation(241), lipid peroxidation(242) and DNA 
damage(243).
H. pylori and ROM production
Studies in vitro have shown that H. pylori and its soluble products could 
activate phagocytes to produce ROM through the oxidative burst(237). Davies 
et al(244)also showed that H. pylori infection is associated with an excessive 
amount of ROM within infected gastric mucosa. They have also shown 
significantly greater free radical production in duodenal mucosal biopsies from 
patients with duodenal ulcer and severe duodenitis(245). ROM production 
correlated well with macroscopic and microscopic mucosal damage, suggesting 
some pathological importance of ROM. The mucosal production of ROM was 
associated with neutrophil infiltration, suggesting that neutrophils are the 
predominant source of ROM.
I.5.4 Cytokine response to H. pylori 
Introduction
Cytokines are proteins or glycoproteins that generally have a molecular weight 
less than 30kda. They generally function as intercellular messenger molecules 
that evoke particular biological activities after binding to a receptor on a 
responsive target cell. Although a variety of cells can secrete cytokines, T 
helper cells and macrophages are two principal producers.
Studies have shown that H. pylori stimulates mucosal production of 
proinflammatory cytokines, including interleukin 8(IL-8), IL-1, IL-6, tumour
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necrosis factor(TNFa) and interferon y(IFN-y). Among these, IL-8 has been ;?f
:l
shown to be the most important in H. pylori-vQlaXod inflammation. Other y:Icytokines including IL-1 and TNFa may be important in regulating the |
production ofIL-8(216).
Interleukin 8 
Source
IL-8 originally purified from conditioned medium of endotoxin-stimulated 
human monocytes, is produced by a variety of cells including
monocytes/macrophages, fibroblasts, endothelial cells, epithelial cells and A1
neutrophils(246~248). Gastric epithelial cells, in common with epithelia from A
'other mucosal sites(249,250) are a major source of IL-8(37,251), It has been #
:|
shown that epithelial cells secrete IL-8 in response to bacterial entry, and A
suggested that epithelial cells serve as an early signalling system to host 
immune and inflammatory cells in the underlying mucosa following bacterial | |
entry(249).
Biological activity
IL-8 belongs to the group of the a-chemokines and acts predominantly on 
.neutrophil granulocytes(36). It is the most potent neutrophil chemotactic 
cytokine known so far(252). It induces degranulation, promotes the attachment 
and transendothelial migration of neutrophils(252,253). IL-8 is also chemotactic 
for T-lymphocytes(254,255). Thus IL-8 is an important determinant regulating 
the trafficking of leukocytes and the development of an inflammatory A
response(256). In contrast to the classic neutrophil chemoattractants(i.e., |
I
:
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formyl-methionyl-leucyl-plienylalanine, platelet activating factor, leukotriene 
B4, and the fifth component of complement, C5a), IL-8 is extremely long-lived 
and is resistant to both high temperature and enzymatic degradation(252,257). 
In addition, a single stimulus will serve to induce continuing production of IL-8 
protein and persisting levels of IL-8 niRNA in vitro(25 8). The persistence of IL- 
8 niRNA and protein when compared with other inflammatory cytokines reflects 
the potency of IL-8 as a leukocyte chemokine.
Regulation
Cytokines rarely act alone in vivo. Multiple cytokines are usually present at any 
site of inflammation, in which they may interact with each other. It has been 
shown that IL-1 and TNFa and LPS can upregulate IL-8 
production(252,259,260). IL-4 and IL-10 inhibit the production of endothelial 
IL-8(256),
H. pylori infection and Il~8
IL-8 niRNA expression in the gastric epithelium and mucosal secretion of IL-8 
from antral biopsies are increased in H. pylori infected patients(251,261,262). 
Studies have shown that expression of IL-8 in gastric epithelial cells may be 
upregulated by the inflammatory cytokines TNFa and y-IFN, as well as by 
direct stimulation by H. pylori products(263). Gastric TNFa(264,265) and ÏL- 
1(266,267) message expression and protein concentration are increased in H. 
pylori-YQl&tQd chronic gastritis. It was shown that both H. pylori LPS or LPS- 
free surface components induced cytokine secretion from peripheral
monocytes(175). It was also suggested that neutrophils may secrete
inflammatory cytokines including IL-1, TNFa and IL-8, which could further
amplify the cellular response to infection(268).
In vitro studies have shown that there are strain to strain variations in their 
ability to induce epithelial IL-8 production. CagA/cytotoxic strains stimulated 
enhanced production of IL-8(269), and it was later shown that CagA positivity, 
rather than VacA(cytotoxin) expression is linked with IL-8 production(270). 
Studies using both strains naturally expressing cytotoxin and/or CagA and their 
isogenic mutants have shown that although CagA expression is closely 
associated with the induction of IL-8, neither Vac A nor CagA is the direct 
inducer of IL-8(271). However, more recent studies suggest that the cagA gene is a 
marker for the presence of a group of genes(the cag pahtogenicity island) in type I 
strains, which may directly regulate the cytokine production(272).
1.5.5 Humoral immune response 
Mucosal antibodies to H. pylori
H. pylori infection is associated with the development of gastric lymphoid 
follicles which are absent in histologically normal m ucosa(ll). These follicles 
may be the source of the increased numbers of plasma cells, which produce H. 
pylori specific antibodies. Using immunohistochemical methods, H. pylori 
coated with specific IgA, IgG and IgM antibodies have been identified in gastric 
biopsies(273). H. pylori specific IgA was found by ELISA in gastric biopsy 
homogenates and gastric juice in infected patients(273-275). IgG plasma cells 
are also increased in chronic gastritis, particularly those of the IgGl
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linked with more active gastric mucosal inflammation and peptic 
ulceration(210).
Systemic antibodies to H. pvlori
patients(152,153). Detection of specific IgG and IgA, especially IgG, has been
subclass(276). Lower levels of IgG, compared with IgA, were detected in gastric 
biopsies(277).
The role of the mucosal H. pylori specific antibodies in the immunopathology of
H. jcy/on-related gastroduodenal disease is unclear. The mucosal IgA is likely to 
be important in inhibiting antigen uptake, blocking bacterial adherence and 
motility of the organism and also in toxin neutralisation(278). It was shown that 
the IgA antibodies inhibit the cell vacuolation induced by if. pylori cytotoxin in
vitro(279). However, current information on the association between mucosal 
antibodies and gastroduodenal disease is limited. CagA, a highly immunogenic 
protein, induces a strong immuno-reactive specific IgA response and has been I
Serum specific IgG, IgA and IgM can be detected in H. pylori infected
1:
used in the serodiagnosis of H. pylori infection, although it cannot differentiate
current infection or a recent past exposure to the bacterium. It is mostly used in 
epidemiological studies.
One study has shown an association between serum anti-77, pylori antibody 
titres and disease severity. IgG titres were shown to be correlated with the 
severity of inflammation both in the antrum and in the body of the 
stomach(280). Serum IgG responses to the 54KD heat shock protein and to the 
vacuolating cytotoxin were correlated with acute mucosal inflammation(281).
■ iIgA responses to whole-cell sonicate and to the cytotoxin were inversely related
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to chronic inflammatory scores(281). Serum IgG antibodies to CagA has been 
shown to be associated with gastric atrophy, as well as peptic ulcer disease, and 
gastric cancer(213,282).
I
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1.6 Aims of Study
Despite recent advances in the understanding of the association between 77. 
pylori infection and chronic gastritis and peptic ulcer, the mechanisms by which 
77. pylori induces gastric inflammation and predisposes to ulcer formation are 
not fully understood. Both bacterial factors and host immuno - inflammatory 
responses are considered to be important in the pathology, although current 
information about the relationship between the two and its importance in 
chronic gastritis and peptic ulceration is still limited.
The studies were designed to investigate the association between the 
toxinogenicity of 77. pylori and host immimo-inflammatory responses in patients 
with chronic gastritis and peptic ulcer. The study will seek to show —
(1) an association between the toxinogenicity of 77. pylori and activation of 
neutrophils isolated from human peripheral blood.
(2) which component(s) of 77. pylori is involved in activating neutrophils.
(3) an association between IL-8 levels and mucosal production of reactive 
oxygen metabolites in patients with chronic gastritis and peptic ulcer disease 
and the nature of their relationship to toxinogenicity of 77. pylori.
(4) a relationship between mucosal IgA 77. pylori antibodies and toxinogenicity 
of 77. pylori and mucosal inflammation.
(5) an effect of eradication therapy of 77. pylori on mucosal immuno- 
inflammatory response.
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CHAPTER 2 PATIENTS AND METHODS
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2,1 Patients 1Patients with dyspeptic symptoms and referred to the Department of A
Gastroenterology at Glasgow Royal Infirmary University NHS Trust for 
endoscopy were recruited consecutively. During the period between 1993-1994,
76 patients from whom 76 strains of H. p y lo r i  were isolated were entered into
.. ..êÿ..the study of “association of cytotoxin and neutrophil activation by strains of 77.
p y lo r i  isolated from patients with peptic ulcer and chronic gastritis”(chapter 3). A
During the period between 1995-1996, another 72 patients were recruited into 
the studies involving “Association of mucosal levels of interleukin-8 and 
reactive oxygen metabolites and their relationship to toxinigenicity of 77.
ipylorf\ch.sy>iQX 5). Some of these patients were also studied for the relationship AI
between mucosal IgA 77. p y lo r i  antibodies and toxinogenicity of 77. AIpy/(9rz(chapter 6). Patients with duodenal ulcer and with 77. p y lo r i  infection were ÿ
selected and treated with eradication therapy(chapter 7). |
I2.2 Endoscopy and Biopsies
Olympus GIQ endoscopes were used. During endoscopy, oesophagus, stomach
•■f
and duodenum were sequentially examined and any abnormalities recorded. 1
Mucosal biopsies were taken using standard size biopsy forceps for histological 
examination including assessment of inflammation and detection of 77. p y lo r i ,  
culture, urease testing(CLOtest) and measurement for ROM, IL-8 and mucosal 
antibodies. All biopsies were placed in appropriate medium and transported to 
laboratories and processed within two hours.
I
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2,3 Histological examination
Mucosal biopsies were fixed in formalin and sent for histological examination. 
Biopsy specimens were stained and examined by an independent pathologist in a 
blinded fashion.
2.3.1 Assessment o f inflammation
The standard haematoxylin and eosin(H&E) staining method was used to assess 
mucosal inflammation. The severity of the mucosal inflammation was graded 
according to degree of infiltration of neutrophils and chronic inflammatory 
cells(mainly lymphocytes and plasma cells)(Table 1).
Table 1 Histological assessment of inflammation of antral mucosa according to 
neutrophil and mononuclear cells infiltration.
Type of inflammation
Scoring(grade)
of inflammation Acute(neuti'ophils per 
high power field)
Clironic
0 (normal)
1 (mild)
2 (moderate)
3 (severe)
0
1-10
11-20
>20
Few scattered mononuclear cells 
Slight increase in numbers of 
mononuclear cells
Moderate numbers of mononuclear cells 
Large numbers of mononuclear cells
iA-
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2.3.2 Detection o f H. pylori
Cresyl fast violet stain was used to detect H. pylori and was found to be simple 
and reliable(140). H. pylori density was graded from 0-3 corresponding to 
absence, rare, moderate or heavy colonisation,
2.4 Cultivation of H. pylori
2.4.1 Transportation o f biopsy specimen and culture
Biopsies were taken at endoscopy and placed in 0.5ml saline and transported to 
the Bacteriology laboratory and processed within two hours. Each biopsy were 
weighed and placed in an Eppendorf tube containing phosphate buffered 
saline(PBS, pH 7,3), The volume of PBS was adjusted to a ratio of one mg 
biopsy/100 pi of PBS. The content was then homogenised gently in a tissue 
homogeniser(BDH, Merck Ltd, Dorset, UK). 10 pi homogenate was then diluted 
with 90 pi of saline, inoculated onto a Columbia blood agar plate and spread 
evenly over the whole surface of the plate using a sterile loop. The plates were 
incubated under microaerobic conditions(5-6%02, 8-10%CO2, 80-85%N2) by 
using a BBL Campypak (BBL, Cokeysville, Massachusetts, USA) at 37°C. The 
plates were inspected daily for up to 7 days.
2.4.2 Identification o f H. pylori
Colonies likely to be 77, pylori were Gram stained and examined 
microscopically for characteristic morphology. Urease activity was tested by 
inoculating a loopful of the organism into 0.25ml of urea containing 
medium(200mM urea and 0.07% phenol red in PBS, pH 7,3), A colour change 
to pink indicated urease positivity, Catalase activity was tested by inoculating 
the suspected colonies into a drop of 3% H2O2 (Sigma, UK) on a glass slide.
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Positivity was indicated by instant formation of bubbles of oxygen. To test for 
oxidase activity, a colony was transferred onto the surface of a commercial 
oxidase strip; a deep blue/black colour change indicated the presence of oxidase.
2.4.3 Semiquantative estimation o f  H. pylori density
' t
'■AÎ
Biopsy homogenates were used to measure H. pylori density by counting the f
colony-forming unit(cfu) at an appropriate dilution. The result was expressed as 
cfu/mg of biopsy.
2.4.4 Preservation o f H. pylori 
A loopful of H. pylori was placed into a Eppendorf tube containing 0.5 ml 
Brucella broth containing 15% foetal calf serum and 15% glycerol and stored at I
-70°C. I 
:To recover the frozen bacterium, the broth containing the organism was thawed
Iand pippetted onto Columbia blood agar plates. The plates were then incubated A
A"microaerobically as described earlier,
2.4.5 Culture o f H. pylori in Brucella broth 
20 ml Brucella broth(Unipath, Basingstoke, UK) containing 5% foetal calf
iserum(Sigma, Dorset, UK) was inoculated with 5 loopfuls of the organism taken f
':Sçfrom agar plates. It was then incubated microaerobically at 37°C on a rotary ■-
shaker at lOOrpm for 48 hours. After 48 h, the broth cultures were examined 
microscopically for the typical morphology of curved bacilli and the percentage of 
coccoid formed strains in each culture was recorded. A broth culture without H. pylori 
was also prepared in the same way as a control.
2.5 M easurem ent o f urease 
Procedure
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Biopsy urease testing was performed using a commercial CLO-test kit(Delta 
West, Australia), which contains agar containing urea and pH indicator. The 
biopsy specimen was placed into the agar medium and a colour change from 
yellow to pink red was recorded as positive.
The urease activity of H. pylori isolates was tested using a urea containing 
medium as described earlier.
2.6 Measurement of H. pylori cytotoxin
2.6.1 Background
Based on the finding that some strains of H. pylori were cytotoxic(208), broth 
culture filtrates of the bacterium caused vacuolation of several cultured cell 
lines such as Vero cells and HeLa cells. Cover et al(203) has established a 
method using neutral red to quantify the degree of cell vacuolation. Neutral red 
is taken up by the vacuolated cells and the amount of the neutral red is 
proportional to the degree of vacuolation present in the cells. Cytotoxic strains 
have been associated with a more serious pathology( 184,210).
2.6.2 Procedure
Brucella broth cultures of H. pylori were obtained as described earlier and 
centrifuged at 4°C at 3000rpm for 15 min. The supernatants were collected and 
filtered through 0.4pm pore size and then 0.2pm pore size membrane 
filters(Millipore, France). The culture filtrates were then transfeiTed to dialysis 
tubing(Sigma, Dorset, UK) capable of retaining molecules with molecular weight 
greater than 12KD and concentrated 20-fold by reverse dialysis versus polyethylene 
glycol(Sigma, Dorset, UK) as described by Taha et al(283). Cultured Vero cells (Fig 2) 
in Dulbecco’s modification of Earle’s maintainance medium(Gibco BRL, A
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Paisley, Scotland) were used to measure intracellular vacuolation caused by the 
cytotoxin according to the methods of Cover et al(192). Each concentrated culture 
filtrate was diluted from 1:5 to 1:160. a 10 pi sample was added to each well 
containing Vero cells in 100 pi Earle’s medium of a 96-well tissue culture 
plates(kindly provided by the Regional Virus Laboratoiy, Ruchill Hospital, Glasgow). 
It was then incubated in a CO2 incubator(5% CO2) for 24 h. Cell vacuolation was 
examined both visually under microscope(Fig 3) and spectrophotometrically by 
following the uptake of neutral red(Fig 4). The maximum dilution of supernatant that 
produced vacuolation was defined as the titre of cytotoxin. For the assay, uninoculated 
broth culture filtrate was used as a negative control.
2.7 Detection of cagA gene in H. pylori
2.7.1 Background
Immunological studies have shown that a subset of H. pylori strains express a 
protein with a molecular weight between 120 and 130 IcDa, and this protein has 
been found to be associated with duodenal ulceration(91,210). Because of its 
close association with cytotoxin production, it has been named cytotoxin- 
associated gene A protein(CagA). The gene encoding the CagA protein has been 
named cagA.
2.7.2 Reagents
TE50 buffer: 50 niM tris, 50 mM EDTA, pH 7.8.
TEIO buffer: lOmM Tris-lOmM EDTA, pH 7.8.
TE buffer: lOmM Tris- IniM EDTA, pH 7.4.
Lysozyme: Sigma, UK
*
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IFig 2 Normal Vero cells(magnification x 400)
U
$ : ; %  %#
t û i > V P !é7- V  .  iv ; . . .  t*^(
m &#
f
Fig 3 Intracellular vacuolation in Vero cells caused by cytotoxin a positive culture 
supernatant of H. py/on(magnification x 400).
^3
%Fig 4 Intracellular vacuolation in Vero cells measured by neutral red uptake 
assay(magnificationx400).
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SDS: Sodium dodecyl sulphate, Sigma ,UK 
Proteinase K: lOmg/ml, Sigma, UK 
Ribonuclease: lOmg/ml, Sigma, UK A
TBE buffer: 86 mM Tris, 89 mM boric acid, 1.2 niM EDTA, pH8.2.
Loading buffer: 25%sucrose, 0.068%sodium acetate, 0.1%SDS, 0.005% 
bromophenal blue.
Primers for cagA PCR: primer 1 5’-AGGAATCTCGCAATTAAGGG-3’
primer 2 5’-TTCTATGCCATTATGACTCCCC-3’
2.73  Procedure 
Extraction o f chromosomal DNA
strains of 77. pylori were cultured on Columbia blood agar plates. Colonies were \
:collected for each strain into 5 ml of TE50 buffer. After centrifugation at 
3000rpm for 10 min, the pellet was resuspended in TE50 buffer and transferred 
to Eppendorf tubes. 50pl lysozyme was added(final concentration at 3mg/ml) on !ice for 30 min followed by the addition of 25pi of 20% SDS(final concentration 
1%) and left on ice for lOmin. 50 pi of proteinase K(1 Omg/ml)(final 
concentration Img/ml) was added and incubated at 56°C in water bath for 2 h.
To extract DNA, 500 pi of phenol-chloroform was added and mixed. After 
centrifugation at 13000rpm for lOmin, the upper aqueous layer was transferred 
to another Eppendorf tube. 500pl of isopropanol was then added and left for 2 h
A
at -20° C. The DNA pellet was resuspended in 0.3 ml TEIO and precipitated by 
the addition of lOOpl of 7.5M ammonium acetate and 600pl of 95% ethanol and 1left at -20°C overnight. The DNA pellet was obtained by centrifugation, and Iresuspended in 0.3ml TEIO. 10 pi ribonuclease(lOmg/ml) was added and iÀ
«
incubated at 37°C for 1 h. DNA was extracted with phenol-chloroform, and 
precipitated with 0.5ml isopropanol and recovered by centrifugation. The DNA 
pellet was dissolved in 0.3ml TEIO, precipitated by the addition of lOOpl 
ammonium acetate and 0.6ml 95% ethanol. The precipitated DNA was obtained 
by centrifugation, rehydrated in 60 pi TE buffer and stored at 4°C.
Polymerase chain reaction(PCR) for cagA gene 
Approximately 20ng of the DNA preparation was used in a PCR mixture of 
25pl(Ready To Go, PCR Beads, Pharmacia, UK) containing 1.5units of Taq 
polymerase, lOmM Tris-HCI, 50mM KCI, 3mM MgCI2, 200pM of each dNTP
picture was taken by a Polaroid camera with a red/orange Kodak filter.
2.8 Measurement of phagocytosis by chemiluminescence
2.8.1 Background
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and stabilizers, including BSA, and 0.2pl of each primer. Primers were selected 
by Ende et al(284) from published sequences(91).
The reaction conditions were as follows: 5 min at 95°C, 30 cycles of 1 min at 
95°C, 1 min at 60° C, and 1.5 min at 72° C, followed by 4 min at 72° C and then 
chilled to 4° C.
Analysis o f the PCR products
The PCR products were analysed by horizontal agarose(1.5%) gel 
electrophoresis, by adding 15pi sample with 5pi of loading buffer into each 
preformed well of the gel. The running conditions were 100 volts for 1 h in an 
electrophoresis tank(Horizon 58, BRL, Life Technologies, UK) containing TBE
Ï
buffer. After electrophoresis, the gel was viewed on an ultraviolet box and a
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Phagocytosis is the process by which bacteria are ingested and killed by white 
blood cells such as neutrophils and macrophages. During phagocytosis, large 
amounts of reactive oxygen metabolites, including superoxide anion, hydrogen 
peroxide and hydroxyl radicals are released.
Luminescence is the emission of light by a non-thermal process. In the case of 
chemiluminescence, the light is produced by a chemical reaction. Luminol is a 
synthetic compound which emits light when oxidized by either peroxides or 
oxygen radicals.
Luminol + H2O2 -----> alpha-aminophthalate + N2 + L fO  + light (425nm)
Measurement of the light released during the reaction can be used to detect 
peroxidase, oxygen radicals or systems producing these substances. The 
intensity of the light released is proportional to the concentration of reactants 
and can be monitored by a light detector called luminometer.
The advantages of the luminescence assay over conventional techniques such as 
colorimetry, spectrophotometry and the counting of radioactive emissions are 
higher sensitivity and specificity, safer use and rapid measurement.
2.8.2 Reagents 
White Cell Separation Reagents 
Polymorphprep™: Sodium Metrizoate, 13.8%, Dextran 500, 8.0%.(Nycomed, 
Binningham, UK).
gel-Hanks solution.- Hanlcs Balanced Salt Solution(HBSS) containing 0.1% gelatin
'White cell counting fluid.- 2% glacial acetic acid(v/v) in distilled water, containing 
lOOpl of 1% methylene blue in 100ml.
Luminol." 5-amino-2,3-dihydro-1,4-phthalazinedine(Sigma, UK).
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Stock solution: lO'^M, working solution lO'^M.
2.8.3 Methods 
Preparation o f bacterial cells
Fresh cultures of H. pylori fi'om Columbia blood agar plates were collected and 
washed three times with sterile saline. A bacterial suspension was prepared and 
adjusted to a concentration of approximately SxlOAmI by diluting the bacterial 
suspension to an optical density(OD) of 0.45 at 620mn.
Isolation of Polymorphonuclear leukocytes(PMNs)
Healthy yoimg adults without a history of peptic ulcer and under no treatment were 
used as white cell donors. Fresh blood samples(40-60 ml for each experiment) were 
obtained and placed into in a universal container with 0.2 ml heparin and mixed by 
inverting gently. PMNs were isolated by using Polymorphprep™ solution and density 
gradient centrifugation. After centrifugation, the PMN layer was removed. The PMNs 
were then washed twice in gel-Hanks solution and standardised to contain IxloAml. 
Chemiluminescence assay to measure bacterial phagocytosis
ROM formation by PMNs in response to stimulation by strains of 77. pylori was 
measured by a luminol-dependent CL assay. Nonopsonised strains or strains 
opsonised with 10% normal human serum(for 30 min) were tested. 50pl of bacterial 
suspension was added to 100 pi of PMN preparation. Just before the assay, 50 pi of 
luminol(10'^ M) was added. The oxidative burst of PMNs was recorded in CPS(count 
per second) in a Luminometer(Canberra Packard, Caversham, UK). The peak 
value(CPS) and the time(min) to reach the peak value were recorded for each strain. A
The assay for each sample was counted at 3-4 min interval for at least 60 min and
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each bacterial suspension was tested tliree times. The average reading for each strain 
was taken.
A
12.9 Measurement of mucosal reactive oxygen metabolites(ROM) by 
chemiluminescence
2.9.1 Background
ROM have been implicated in many inflammatoiy disorders, including those of the ":W
gastrointestinal diseases(285). The infiltration of neutrophils and monocytes 
associated with gastrointestinal mucosal inflammation can provide an important 
source of ROM via the enzymes of the respiratory burst(NADPH oxidase and 
myeloperoxidase) and those involved in prostaglandin and leukotriene
A:
metabolism(286).
Luminol can react with oxidants such as ROM to fonn 3-aminophthalate and N- 
methylacridone. The excited electrons in these compounds revert to their ground state 
with the emission of light(luminescence), which can be detected by a light detector 
such as huninometer(287).
2.9.2 Procedure
I 
:
Each biopsy specimen was bathed in and transported separately in a small volume of 
phosphate buffered saline(pH 7.3). After the biopsies were weighed, luminol- 
enlianced CL was performed using a luminometer(BioOrbit, UK), in which the light 
emission accompanying the generation of ROM is measured and the intensity of light 
produced expressed as millivolts(mv). Tubes containing one ml of 50 pM luminol 
were measured for background chemiluminescence. After addition of the biopsy.
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sample tubes containing one ml of 50 pM luminol were remeasured for 5 min. The 
results were expressed as mv/min/mg biopsy after subtraction of the background.
2.10 Measurement of mucosal levels of IL-8
2.10.1 Background
IL-8 is a potent chemotactic factor and activator of neutrophils. By using 
measurements of mRNA and the protein levels of IL-8, it was found that H. pylori 
infected gastric mucosa displayed increased expression of IL-8.
2.10.2 Procedure 
Sample preparation
Each gastric antral biopsy was immediately washed with phosphate buffered 
saline(pH 7.3), weighed and placed in an Eppendorf tube containing 0.5ml phosphate 
buffered saline(pH 7.3). It was then homogenised using a glass grinder(BDH, UK) at 
4°C. The resulting suspension was centrifuged at 2000 g for 10 min and the 
supernatant collected and stored at -70°C before measurement of IL-8.
Measurement of IL-8 by ELISA 
IL-8 was measured by ELISA(Bio-Whittaker, UK), each assay being performed in 
duplicate according to the manufacturer’s instinctions. Briefly, microwell strips 
coated with monoclonal antibody to human IL-8 were washed before 50 pi of each 
sample supernatant was added. 50 pi of diluted conjugate was then added to every 
well including those containing IL-8 standard and incubated for 2 h. After washing, 
100 pi substrate solution was added and incubated for 15 min. The enzyme reaction 
was stopped by the addition of 4N sulphuric acid and the absorbance was measured by 
an ELISA reader(Labsystems, UK) set at 450 nm. The concentration of IL-8 in each
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sample was calculated against a standard curve. The results were expressed as pg/mg 
biopsy.
2.11 Measurement oiH. pylori antibodies
2.11.1 Background
H. pylori infection induces significant local and systemic immune responses. 
Various serological tests have been developed to detect specific antibodies to
Biopsy specimen preparation
preparation for measurement of IL-8 described earlier. 
Measurement o f H. pylori antibody by ELISA
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'the bacterium. IgG isotype has been used widely in serological studies, while
IgA is the predominant isotype at the local mucosal level and in gastric juice.
■A
Current commercial ELISA kits using partially purified antigens containing 
urease, provide fairly high sensitivity and specificity(155,156).
2.11.2 Methods
Sample used for measurement of mucosal antibodies was the same as the sample
I
Mucosal H. pylori antibodies were measured by using ELISA kits(Sigma, UK) 
in duplicate according to the manufacturer’s instructions. The procedure was as
follows. The samples were diluted 1 in 50 in PBS/Tween 20(0.25%) and 100 pi 
was added to each well. The plates were incubated at room temperature for 40 
mill and then washed three times in PBS/Tween 20. Diluted(l to 5000 in 
PBS/Tween 20) peroxidase conjugated goat anti-human IgA was added to each
well(Sigma, UK). The plates were then incubated at room temperature for 30
min. After washing three times, 100 pi of substrate solution(containing DMB
and H2O,) was added and incubated at room temperature for 20 min. The 
'
reaction was stopped by adding 100 pi of 2.5 N sulphuric acid. The optical 
density(OD) at 450 nm was measured on the Titertek Multiscan plate 
reader(Flow Laboratories, Irvine, Scotland, UK). Two reference samples(one 
positive and one negative) were also included in each experiment. Antibody 
positivity was defined as the OD value greater than 2 SD(standard deviation) of 
the mean OD of H. pylori~YQ samples. The antibody titre was expressed as 
follows: Antibody titre = (sample OD - (mean T 2 SD of negative OD))x 1000.
2.12 Eradication therapy ofÆ pylori infection
2.12.1 Background
Studies have confirmed the association between H. pylori infection and the 
development of peptic ulceration and the eradication of the organism leads to the cure 
of peptic ulcer associated with the infection. Eradication therapy is recommended in 
patients with peptic ulcer disease with H. pylori infection. Current preferred regimes 
for H. pylori eradication include a proton pump inliibitor(such as omeprazole or 
lansoprazole), and two antibiotics such as metronidazole and clarithromycin.
2.12.2 Patients and treatment regimen
Patients with duodenal ulcer and infected with H. pylori were treated with 
lansoprazole 30 mg daily for four weeks, metronidazole 200 mg three times daily for 
one week and clarithromycin 250 mg tliree times daily for one week. s
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CHAPTER 3
Association of cytotoxin production by strains of Helicobacter 
pylori isolated from patients with peptic ulceration and chronic
gastritis and neutrophil activation
3.1 Introduction
The mechanisms by which H. pylori causes gastroduodenal mucosal damage are 
not well established. Free oxygen radicals have been implicated in a wide 
spectrum of human diseases(239), including gastrointestinal disorders(32,285) 
and may play an important role in the development of gastroduodenal 
inflammation and peptic ulceration(244). A prominent histological feature of 
infection with H. pylori is a dense infiltration of polymorphonuclear cells in the 
epithelium and the underlying lamina propria, which could provide an important
A
source of free radicals(238). Once activated, the neutrophils release free oxygen 
radicals which may damage mucosal integrity(288). There is evidence to show 
that H. pylori stimulates gastric antral mucosal reactive oxygen radical 
production in vz'vo(244).
Several potential virulence factors of H. pylori such as cytotoxin and urease 
may contribute to mucosal damage(190,165). Recent studies suggest that the 
cytotoxin and the CagA protein are associated with peptic ulceration and 
chronic active gastric inflammation(l89,93). :
Surface proteins of H. pylori which contain urease have been shown to activate Ihuman blood monocytes(175), leading to the secretion of inflammatory 
cytokines and reactive oxygen intermediates, although the protein(s) involved
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was not identified. Another protein with an estimated molecular weight of 
150KD has also been associated with neutrophil activation(289).
3.2 Aims of study
To investigate whether a relationship exists between cytotoxin-producing strains 
of H. pylori and the generation of free oxygen radicals by neutrophils and to 
determine whether a relationship exists between neutrophil activation and 
disease status.
3.3 Patients and experimental design
.76 patients undergoing endoscopy in Glasgow Royal Infirmary were recruited, 
consisting of 45 with peptic ulcer(36 duodenal ulcer, 9 gastric ulcer), and 31
I
with chronic gastritis only. 44 patients were male(age between 20-75, mean 57),
.and 32 were female(age 24-73, mean 55). At endoscopy, gastric biopsies were
taken for culture, CLO test(Delta West Ltd, Australia) and histology.
76 clinical isolates of H. pylori isolated from each of the 76 patients were
studied; All were positive for urease, oxidase, catalase and showed typical
morphology under light microscopy. For cytotoxin measurement and
chemiluminescence(CL) assay, the strains were cultured in Brucella broth
containing 5% foetal bovine serum at 37° C under microaerophilic conditions as
described in chapter 2. After 48 h, the broth cultures were examined
microscopically for the typical morphology of curved bacilli and the percentage 
.of coccoid forms in each culture was recorded. The percentage was found to be
similar for all the strains in this study, which was 18-20%. The cultures were 
then centrifuged at 3000rpm for 15min, the bacterial cells collected for CL 1;s'..■s
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assay, and culture supernatants for cytotoxin assay. A broth culture which had 
not been inoculated with H. pylori was also prepared in the same way.
The cytotoxin assay was performed following the method described
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Iearlier(ehapter 2).
Free oxygen metabolites(ROM) formation by polymorphnuclear 
neutrophils(PMNs) in response to H. pylori was studied by a luminol-dependent 
CL assay, following the methods described earlier(chapter 2). Peak CL count(as 
CPS) and the time to reach peak(in minutes) were recorded. Figure 5 shows two 
representative curves of CL induced by two strains of H. pylori.
76 nonopsonised strains and 42 strains opsonised with 10% normal human 
serum were tested in parallel. Healthy young adults without a history of peptic 
ulcer disease and under no treatment were used as white cell donors. Sera used 
for opsonisation were tested for anti-7/, pylori IgG antibodies by ELISA.
I
Statistical methods
5,
X2 test and Student's t test were used for two group comparisons. A two-way 
analysis of variance and multiple comparison procedure was used to determine 
the independent effect of toxinogenicity and the presence/absence of peptic 
ulcer on the PMN chemiluminescence response induced by strains of H. pylori.
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Fig 5 Chemiluminescence(count per second, CPS) induced by 
two representative strains of H. pylori. Strain 1 induced a stronger 
and quicker CL response than strain 2.
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3.4 Results 
Production o f cytotoxin
Concentrated culture supernatants from 39/76(51.3%) of the isolates of H. 
pylori produced measurable cell vacuolation. Among the strains from peptic 
ulcer patients 30/45(66.7%) induced cell vacuolation versus 9/31(29%) strains 
from patients with chronic gastritis only(p<0.01) (Table 2). Some variation in 
toxinogenicity of the various strains was seen with titres of toxin ranging from 
0 to 160.
Table 2 Cytotoxin production by strains of U, pylori isolated from 76 
patients with either peptic ulcer or chronic gastritis only.
Toxinogenicity Prevalence among patients with
of strains Peptic ulcer Chronic gastritis only
Tox + 30/45^ 9/31
Tox - 15/45 22/31
* p<0.01, compared with patients with chronic gastritis only(X^ test).
Generation o f reactive oxygen radicals measured hy chemiluminescence
Figure 6 shows the chemiluminescence response induced by 76 non-opsonised 
strains of H. pylori. It shows that there is strain to strain variation in the ability 
to induce an oxidative burst in PMNs displayed by the difference in the peak
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to induce an oxidative burst in PMNs displayed by the difference in the peak 
count(KCPS) and the time to reach peak(min). Some produced a stronger and 
more rapid response than others. The CL pattern for each strain was 
reproducible. Although there are some small variations in peak height for each 
strain on each test occasion, the peak time was fairly constant(Table 3).
Table 3 Chemiluminescence(CL) response induced by two representative 
strains o f H. pylori in three experiments.
Strain number test Peak value(Kcps) Peak time(min)
5617B 1 534 15
2 490 15
3 458
494(38.2)*
16
7994K 1 118 39
2 90 40
3 71
93(23.6)*
40
f
■"i
:
..1fiIft
a
ft-
* Mean(standard deviation, SD), Strain 5617B induced a higher 
and quicker CL response. 7994K induced a weaker and slower one.
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Fig 6 Neutrophil respiratory burst induced by 76 clinical 
isolates of H. pylori. Results are the mean of three separate 
experiments and shown as peak count(KCPS) and the time 
to reach peak(min).
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Reactive oxygen radicals, cytotoxin production and the presence o f peptic 
ulcer disease
Using a two-way analysis of variance approach, the effect of toxin status and 
the presence or absence of peptic ulcer on each strain’s ability to induce a CL
response in terms of peak count and the time to reach peak were investigated. 
The results are summarised in Table 4 and show that the CL response in terms 
of peak count induced by toxin positive strains regardless of the presence or 
absence of peptic ulcer(groups 1 and 2) is higher than that induced by those 
toxin negative strains from patients without peptic ulcer(group 4)(p<0.05). It 
also shows that toxin positive strains(groups 1 and 2) take less time to induce 
peak CL than those strains of group 4(p<0.05). These results indicate that the 
toxinogenicity of H. pylori may have a significant effect on the CL response, 
although there is no significant difference between toxin positive strains(groups 
1 and 2) and group 3 which were toxin negative but associated with peptic 
ulceration(p>0.05). However, Among the toxin negative strains, those from 
patients with peptic ulcer failed to show any significant enhancement of the CL 
response compared to those from patients without peptic ulcer(group 4)(p>0.05) 
in terms of peak count and the time to reach peak.
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Table 4 Peak count and time to reach peak in the chemiluminescence 
response induced by 76 strains of H. pylori in relation to the toxinogenicity and 
the presence or absence of peptic ulcer disease.
Group Characteristic No MeantSDl
Peak count(Kcps) Time(min)
1 Tox+ Ulcer+ 30 295.1(128.1)* 18.8(9.86)
2 Tox+ Ulcer - 9 346.2(193.9)^ 21.1(11.2)'
3 Tox - Ulcer+ 15 245.3(139.8) 25.6(12.8)
4 Tox - Ulcer - 22 175.7(116.7) 31.1(11.3)
*p< 0.05 with a 95% CI(38.6, 200.6) for difference in means between group 1 and 4. p<0.05, 
95% CI(5.7, 335.3) between 2 and 4.^p<0.05, 95% CI(-19.6, -5.2) between 1 and 4.
®p<0.05, 95%CI(-19.2, -0.9) between 2 and 4. (Two-way analysis of variance and multiple 
comparison).
I
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When opsonised with 10% human serum, most strains of H. pylori resulted in a 
stronger and more rapid CL response than when non-opsonised. A few(7/42)
■.si
strains which induced a high CL response when non-opsonised gave a slightly 
decreased peak count(mean decrease:65.4+36.5), while the time to reach peak ;S
Group Characteristic No  MeantSDl
1 Tox+ Ulcer+ 15 522.1(165.7) 13.4(3.7)
2 Tox+ Ulcer - 7 504.3(168.4) 13.4(3.6)
3 Tox - Ulcer+ 10 472.5(128.4) 13.5(3.8)
4 Tox - Ulcer - 10 440.2(159.6) 14.5(4.7)
p>0.05 , Two-way analysis of variance.
was relatively unchanged. As can be seen from Table 5, there is no significant
liftdifference between the four groups of straiiis(p>0.05), indicating that the toxin 
status and the presence/absence of an ulcer do not affect the CL response if
induced by opsonised strains. The presence of IT. pylori antibody in any sera 
used for opsonisation did not affect the results. JTable 5 Peak count and the time to reach peak in the chemiluminescence 
response induced by 42 opsonised strains of 77 pylori in relation to the 
toxinogenicity and the presence or absence of peptic ulcer.
Peak count(Kcps) Time(min) 4
-----------------------------------------
Ï
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3.5 Discussion and Conclusion
From the study, 66.7% nonopsonised strains of H. pylori from peptic ulcer 
patients induced cell vacuolation, which is significantly higher than those from 
patients without proven peptic ulcer(29%). This supports a previous report that 
the cytotoxin-producing strains were more frequently found in patients with 
peptic ulcer(189). Using a two way analysis of variance approach, the effect of 
toxinogenicity and the presence/absence of peptic ulcer on the oxidative burst 
induced by non-opsonised strains of H. pylori was investigated. It was found 
that cytotoxin-producing strains have an increased CL response in terms of 
higher peak count and shorter time to reach peak than those toxin negative 
strains from patients without peptic ulcer. These results support a possible link 
between the neutrophil respiratory burst and the toxinogenicity of strains of H. 
pylori. The association of certain strains with peptic ulcer disease per se did not 
influence significantly the CL response of human PMN. However, this finding 
does not exclude a possible relation between the neutrophil respiratory burst and 
peptic ulceration, since most strains from peptic ulcer patients(66.7% in this 
study) are cytotoxin-producing. Also we cannot rule out the possibility that 
some chronic gastritis patients infected with a cytotoxin-producing strain might 
have had an ulcer in the past or may develop one in the future.
Most opsonised strains of IT. pylori gave an increased CL response in our study 
and the serum antibody to H. pylori showed no effect on the CL response. This 
is consistent with previous reports(290,291) which suggested that serum 
complement rather than serum antibody is the main opsonin in this respect. 
However, it is not certain whether complement-mediated opsonisation occurs
83 g
  . . . . .
within the gastric mucosa during H. pylori infection. A few opsonised strains 
gave a decreased CL response as compared to the same strains non-opsonised. 
The reason for this is not known; some serum proteins may act as electron 
scavengers(292).
Other investigations have shown that there are some differences between strains 
of H. pylori in their ability to produce cytotoxin and CagA protein and to cause 
peptic ulcer disease(210). Although host factors play a very important role in 
the genesis of peptic ulcer, there is increasing evidence from molecular biology 
and immunology for the division of H. pylori strains into at least two major 
groups-one producing the CagA protein and cytotoxin(Type I) and one that 
does not produce either of these antigens (Type II)(215). This study showed 
there is strain to strain variation in the ability to produce cytotoxin, and to 
induce an oxidative burst in PMNs.
Previous studies have shown that CagA/cytotoxin positive strains of H. pylori 
are associated with the infiltration of neutrophils within the gastric 
mucosa(192,210) and also related to an increased expression of interleukin-8, 
which is a novel cytokine capable of activating neutrophils. Based on these 
results and the findings in this study which indicate a positive association 
between the neutrophil respiratory burst and the cytotoxicity of H. pylori which 
is also associated with peptic ulceration, it seems, therefore, that 
cytotoxin/CagA positive strains may induce a more aggressive inflammatory 
response through secretion of toxic component(s), production of cytokines by 
gastric mucosal cells, recruitment of neutrophils, release of free oxygen
S
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radicals, and subsequently cause tissue damage, which may lead to peptic 
ulceration.
There were some strains that did not produce cytotoxin but which could induce 
a high CL response, raising the possibility that some H. pylori product(s) other 
than cytotoxin may be important in this respect. So far the nature of the 
component(s) of H. pylori which activates neutrophils is uncertain. Several
peptic ulceration.
reports have suggested that the activity is mainly caused by a protein(s), 
although some non-protein molecules such as lipopolysaccharides(LPS) may 
also be implicated(l75,176). There is a possibility that the gene encoding for the 
protein which activates PMNs is more strongly expressed on the so-called Type 
I strains that produce cytotoxin and CagA protein.
In conclusion, cytotoxin-producing strains of H, pylori appears to be correlated :.with increased free oxygen radical formation by neutrophils and peptic 
ulceration. The ability of some H. pylori strains to produce cytotoxin and to 
induce an oxidative burst of neutrophils may be important in the pathogenesis of
t
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Chapter 4
Neutrophil activation by soluble proteins of Helicobactet pylori
involved.
4.3 Experimental design
response and produced cytotoxin was subjected to various forms of column 
chromatography. Eluted fractions were tested for cytotoxin, urease activity and
86
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4.1 Introduction
In vitro and in vivo studies have suggested H . pylori induces a neutrophil 
oxidative burst and a subsequent release of reactive oxygen metabolites(235- 
237,244,245). However, the component(s) of H. pylori responsible for the 
activation of neutrophils is still inconclusive. It has he en suggested that some 
bacterial components of 77. pylori have chemotactic and/or activating property ®Ifor leukocytes, including a neutrophil-activating peptide(NAP) and 
lipopolysaccharide(LPS)(289,293). Previous studies have suggested that |
cytotoxic strains may induce an enhanced neutrophil oxidative burst(294,295), 
whereas it is not known whether the cytotoxin per se of 77, pylori can activate 
neutrophils.
4.2 Aims
To investigate the possible coniponent(s) of 77. pylori culture supernatant which
.induces LMN chemiluminescence response and to see whether the cytotoxin is ft
A culture supernatant from a strain of 77. pylori which stimulated a strong CL ft/ftl
ftability to induce CL in PMN. The methods are described below —
mill at 100°C in a water bath. Each test was performed three times.
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The cytotoxin producing strain was cultured microaerobically in Brucella broth 
containing 0.5% charcoal(untreated, granular 8-20 mesh, Sigma, UK). After 48 
h, the broth culture was centrifuged at 3000 g for 30 min. The supernatant were 
than filtered through 0.4pm and then 0.2pm filters(Millipore, France). The culture 
filtrates were then concentrated 20-fold by reverse dialysis versus polyethylene glycol 
as described previously(Chapter 2).
Column Chromotography
2 ml of concentrated culture supernatant was applied to a Sephadex G-200
column with buffer containing 60 mM Tris and 0.1 M NaCl(pH 7.7) at a flow
ft
rate of 0.2ml/min. The eluted proteins were monitored by UV absorbance at 
280nm. Individual fractions showing cytotoxin activity were subsequently 
applied to a Hi-load Q column(Pharmacia) with 20 mM Tris(pH 7.7), and the 
proteins were eluted with 20 mM Tris containing a linear gradient of 0-lM  
NaCl over 100 ml. The chromatograms are shown in Figures 7 and 8. The 
fractions were tested for cytotoxin and urease activity as well as for their 
ability to activate neutrophils.
Measuring neutrophil activation by chemiluminescence
Fractions were tested for neutrophil activating property by chemiluminescence(CL)
using a luminometer(Bio-orbit). The assay was performed by adding 100 ul of each 
.protein fraction to 100 ul of PMN(10/ml) and 100 ul of luminol(lO'^M). CL was 
expressed as mv and the peak(mv) and peak time(min) were recorded. The effect of 
proteinase K and heat treatment on the activity of the protein fractions were tested ft
either by treatment of the fi'actions with 2mg/ml proteinase K or by heating for 20
".•li'ï
4.4 Results
Gel chromatography
Fig 7 shows that Sephadex G-200 gel chromatography yielded two protein 
,peaks. Fractions of protein peak 1 were shown to be urease positive and 
cytotoxin positive. They were also shown to induce a neutrophil oxidative burst.
These fractions was then purified further by applying to an ion exchange 
column. As can seen from Fig 8, three protein peaks(a, b, c) were separated 
following elution with a gradient concentrations of NaCl from 0-lM. Fractions 
from peak b showed both cytotoxin and urease activity.
Neutrophil activation 
Fractions from protein peaks a, b and c were tested for neutrophil activating 
activity (Fig 9). Protein peaks a and c induced a rapid CL response, whereas 
protein peak h containing cytotoxin and urease only showed only a slow and in­
significant CL response.
There was a dose-dependent CL response in terms of the ability of protein peaks 
(a) and (c ) to induce an oxidative burst(Table 6). After the treatment of 
proteinase K(2mg/ml) for 1 h, the neutrophil activating activities of protein 
peaks (a) and (c ) were significantly decreased. However, heat treatment did not 
reduce the activity.
!
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Table 6 Chemiluminescence(CL) induced by protein peaks (a) and (c ) at 
different concentrations and the effect of proteinase K and heat treatment on the 
CL response.
Peak Peak time Mean
Protein (mv) (min) (mv)
Protein (a) lOug/ml 5.0 20 4.42
5 ug/ml 4.2 21 2.71
2.5 ug/ml 3.1 23 2.21
10 ug/ml+proteinase K 1.7 28 1.60
10 ug/ml, 100°C x20 min 5.3 20 4.51
Protein (c) 10 ug/ml 3.2 21 2.0
5 ug/ml 2.6 23 1.7
2.5 ug/ml 2.2 26 1.6
lOug/ml+proteinase K 1.4 - 1.38
lOug/ml, 100°C x20 min 4.1 20 2.4
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4.5 Discussion
It was found in this study that soluble products of H. pylori could activate 
neutrophils to release reactive oxygen metabolites. Chromatography showed 
that there were two protein peaks capable of inducing the CL response,
9
suggesting that more than one product of H. pylori was capable of activating 
neutrophils. The results also showed that the neutrophil activating activity was Îdestroyed or nearly abolished by incubation with proteinase K, suggesting the 
active components might be polypeptides. However, it is unclear why heat 
treatment did not abolish the activity as might be expected of a protein.
Previous studies in vitro suggested cytotoxin-producing strains are more likely 
to induce a stronger neutrophil oxidative burst(294,295). The results in this 
study have shown that cytotoxin containing fractions from chromatography did g
not induce a significant CL response suggesting that the cytotoxin per se is not I
the active component. Urease also is unlikely to play a significant role in Ineutrophil activation, because urease containing fractions failed to induce a Ssignificant CL response. However, urease has been shown by others(175) to 
activate monocytes/macrophages. g
Evans et al(289) described a protein with a molecular mass of 150 Kd, which 
has a significant neutrophil-activating property, namely H. pylori neutrophil 
activating peptide(HP-NAP). The nap A gene encoding the protein was 
characterised and was shown to be present in all strains of H. pylori tested, but %
it appeared that there is strain to strain variation in the expression of the HP- #
-jT'.
NAP in vitro(289). It is possible that some of the protein fractions tested in this 
study contained the NAP protein.
I
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In conclusion, H. pylori may secrete several soluble products, possibly proteins, 
capable of activating neutrophils. The neutrophil activating activity seems to be 
independent of cytotoxin and urease activity. Further studies are needed to 
characterise the proteins responsible and to elucidate their clinical importance in
H. joy/on-induced gastroduodenal disease.
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CHAPTER 5
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Association of antral mucosal levels of interleukin-8 and reactive
oxygen metabolites, and their relationship to toxinogenicity of
I%Helicobacter pylori I5.1 Introduction ■
Helicobacter pylori{H. pylori) infection has now been considered to be the main |
I
Ï
cause for chronic gastritis and is closely associated with the development of peptic 
ulcer disease(l-4), although the mechanisms by which H. pylori induces mucosal
■
inflammation and peptic ulceration are still not well understood. Only some patients 
with H. pylori infection developed serious pathology such as peptic ulcer disease. IDifferences in bacterial virulence factors among strains of H. pylori and in individual I
'host response to the bacterium are considered to be important in explaining the |;
different clinical outcome(32-34). Currently, two bacterial virulence factors of H.
%pylori, CagA protein(encoded by cagA gene) and the vacuolating cytotoxin(VacA, Iencoded by vac A), have been suggested to be more frequently expressed in strains Jisolated from peptic ulcer patients than in those with clrronic gastritis only(210,189).
ÎInflammatory cell infiltration including neutrophils and mononuclear cells is r:Icharacteristic of the gastric mucosal pathology associated with H. pylori infection.
Recent studies have shown that H. pylori can activate neutrophils in vitro(235- f
■
237), implicating that neutrophil activation may be important in H. pylori- 
induced mucosal inflammation. Neutrophil activation is an important source of gI
reactive oxygen metabolites(ROM) which are known to cause tissue 
damage(238,288). Studies in vitro have shown that H. pylori infection is
:{
associated with a neutrophil oxidative burst(176,296). H. pylori infection has 
also been shown to be associated with an in vivo mucosal production of ROM 
and higher antral colonisation levels of H. pylori are associated with increased 
production of ROM(244,297).
The intensity of the inflammatory cell infiltrate has been correlated with the severity 
of mucosal injury(297,298). Interleukin 8(IL-8), a chemokine which attracts and 
activates phagocytes, especially neutrophils, has been shown to be important in 
leukocyte-mediated tissue injury(259). Recent studies have shown that gastric 
mucosal IL-8 is significantly increased in H. pylori infected patients, suggesting an 
important role of IL-8 mediated leukocyte trafficking in H. pylori induced 
inflammation(37,259).
However, there are considerable variations among the infected patients in the mucosal 
expression of IL-8 and the mucosal production of ROM(37,261). Recent studies in 
vitro have suggested that IL-8 production is enhanced by cytotoxic/cagA positive 
strains of H. pylori and cagA is considered to be a marker for IL-8 induction(214,269- 
271). In vitro studies also suggested that cytotoxin-producing strains may induce 
a stronger oxidative burst in neutrophils(294,295).Currently there are limited data 
on the association between the different types of 77. pylori strains and the in vivo 
mucosal production of IL-8 and ROM.
5.2 Aims of Study
To investigate (1) whether there is any association between antral mucosal 
production of IL-8 and ROM; and (2) what their relationship is to 
toxinogenicity of H. pylori', and (3) what their relationship is to gastric antral 
inflammation.
a
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5.3 Patients and experimental Design
Patients referred for endoscopy in the Department of Gastroenterology in Glasgow 
Royal Infirmaiy were recruited prospectively during the period between 1994-1996. 
Patients were excluded if they had previous gastric surgery, had previous H. pylori 
eradication therapy, or were on antibiotics or non-steroidal anti-inflammatory dmgs. 
In total, 72 patients aged between 23 and 78 years(median 41) were eirrolled. These 
included 36 patients with peptic ulcer(32 duodenal ulcer, 4 gastric ulcer) and 36 with 
non-ulcer dyspepsia. Patients had been advised to stop any anti-acid therapy or ulcer- 
healing dmgs at least two weeks prior to endoscopy.
During endoscopy, gastric antral biopsies were taken using the same size 
forceps from similar topographical sites at each endoscopy for histology, 77. 
pylori culture, CLO test, measurement of tissue levels of IL-8 and 
chemiluminescence(CL). Histological identification of 77 pylori in sections stained 
with H&E and cresyl violet if necessary was assessed by an independent pathologist 
in a blinded fashion and mucosal inflammation was also scored according to the 
degree of infiltration of neutrophils and mononuclear cells as described earlier(Table 
1). Semiquantitative assessment of colonisation density of 77. pylori was 
performed by counting the number of colony forming units(cfu) per mg tissue 
on culture plates. Cytotoxin production was tested by detection of intracellular 
vacuolation using cultured Vero cells. The cagA gene expression of 77. pylori 
strains was determined by PCR. The PCR products were analysed by horizontal 
agarose(1.5%) gel electrophoresis(Fig 10). Antral mucosal levels of IL-8 were 
measured by ELISA. Mucosal production of ROM was measured by lumiiiol-
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Fig 10 Expression of cagA gene in 11 strains of H. pylori analysed by PCR and 
agarose gel electrophoresis(1.6%). Lane 1 and 13: DNA ladder(123bp). Lane 2. 
reference strain (NCTC 11637). Lane 3, 4, 6, 8, 9, 10, 11. cagA+ve clinical isolates. 
Lane 5,7 and 12: cagA-ve clinical isolates. Estimated PCR product: 750 bp.
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enhanced chemiluminesence assay. Detailed methods were described in chapter
99
2.
Reproducibility o f  measurement o f IL-8 and ROR
The reproducibility of the two tests were assessed by taking more than one 
specimen from the same site in each patient. The median(interquartile) 
percentage disagreements between biopsies from each patient were 8.1%(0.8 to 
14.1%)(n=22) for IL-8 and 13.2%(4.1 to 19.5%)(n=32) for CL assay. These 
variances were relatively small compared to the differences found between 
patients.
Statistical analysis
The Kruskal-Wallis test was used for multiple group comparisons and the 
Mann-Whitney U test for two-group comparisons. Pearson’s correlation analysis 
was applied to the association between IL-8 levels and ROR production. The 
relationships between the microscopic inflammation score and IL-8 
concentration and ROR production were assessed by Spearman’s rank 
correlation. P values <0.05 were considered to be statistically significant.
5.4 Results
Correlation between detection methods for H. pylori in antral mucosa
There is a good correlation between the results of H. pylori culture, CLO test 
and histological identification of H. pylori. The positivities of the three tests 
were similar in the biopsies examined; H. pylori was detected by all tlmee tests in 
all 36 peptic ulcer patients(100%) and in 16 of 36(44.4%) of those with NUD. 
Detection of cagA gene and cvtotoxin(VacA) in H. pylori strains
Among the 52 strains of H. pylori isolated, 35 expressed cagA gene(cagA+ve), and 30 
produced vacuolating cytotoxin(VacA+ve). Of the 35 cagA+ve strains of H. pylori, 
25(71%) were cytotoxin positive. In those 30 VacA+ve strains, 25(83.3%) were 
cagA+ve. Correlation between clinical findings, cagA gene expression and cytotoxin- 
producing status of 77. pylori strains is summarised in Table 7. 29 of 36(80.6%) strains 
of 77. pylori isolated from peptic ulcer patients were cagA positive compared to 6 of 
16(37.5%) strains from patients with non-ulcer dyspepsia(p=0.005). 24 of 36(66.7%) 
strains from peptic ulcer patients produced cytotoxin compared to 6 of 16(37.5%) 
strains from patients with NUD(p=0.045).
Table 7 Expression of cytotoxin(VacA) and possession of cagA gene of strains of 77. 
pylori in patients with peptic ulcer and non-ulcer dyspepsia.
Patient group Characteristics of strains No of patients 
PU NUD
Total
1 VacA+ cagAH- 20 5 25
2 VacA- cagA+ 9 1 10
3 VacA+ cagA- 4 1 5
4 Vac A- cagA- 3 9 12
There was a good correlation between 77. pylori colonisation density measured 
by viable cell counts in culture and that assessed by the histological detection 
of the organism in biopsies taken from the same area(Fig 11 1-0.58, n=44,
p<0.01).
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Fig 11 Correlation between H. pylori density assessed by 
viable count(cfu) in culture and that assessed by 
histological grading of density.
Effect o f  H. pylori infection on gastric mucosal production o f  IL-8
Mucosal Levels of IL-8 were significantly increased in samples of antral 
mucosa colonised with H. pylori compared to those without H. pylori, 
regardless of the presence or absence of peptic ulcer(p<0.05). The levels of IL-8 
in those with peptic ulcer was slightly higher than that in those with NUD and 
with H. pylori infection(p=0.034)(Table 8). No independent effect of patients’ 
age, sex, smoking habit and alcohol consumption was found on mucosal levels 
o fIL -8(Table 9).
Table 8 Antral production of IL-8(pg/mg) in patients with peptic ulcer and non-ulcer 
dyspepsia(NUD) with or without H. pylori infection.
Patient group No Mediant interquartile!
IL-8 (pg/mg) R.OM.{mv/min/mg)
Peptic ulcer 36 1.50(0.88-2.47)** 517(45, 730)'"'
Non-ulcer dyspepsia
with H. pylori 16 0.80(0.45-1.55)* 143(9, 119)"
without H. pylori 20 0.20(0.00, 0.70) 0(0, 3)
^■p=0.02 compared to NUD patients without H. pylori', '^*p=0.034 compared to NUD patients with H. 
pylori. ^p<0.001 compared to NUD patients without H. pylori. ^ ^ p=0.03 compared to NUD patients 
with Æ pylori.
Effect o f H, pylori infection on mucosal production o f ROM
Patients infected with H. pylori showed significantly higher levels of ROM 
production(median(interquartile)mv/min/nig) than patients without infection 
regardless of the presence or absence of peptic ulcer(p<0.001). The mucosal 
levels of ROM in peptic ulcer patients were relatively higher compared to those 
patients with NUD(p=0.031)(Table 8). A good correlation was found between
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antral H. pylori density and mucosal ROM release(i-0.68, p<0.001, Fig 12). No 
correlation was found between mucosal ROM and other factors including 
patient's age, sex, smoking habit and alcohol consumption(Table 9).
Table 9 Demographic data of patients’ sex, age, smoking habit and alcohol 
consumption and mucosal production of IL-8 and ROM
Patient No MedianQO ranse! levels of
p valueIL-8 (pg/mg) ROM(mv/min/mg)
Sex
Male 35 0.91(0.44, 1.50) 36(1, 204) NS
Female 37 0.70(0.30, 1.65) 30(0, 196)
Age
20-30 13 0.77(0.25, 3.30) 29(1, 805)
31-40 19 0.78(0.50, 1.65) 75(4, 380)
41-50 12 0.40(0.29, 1.52) 56(0, 192) NS
51-60 16 0.95(0.40, 1.65) 20(0, 106)
>61 12 0.70(0.50, 1.00) 30(0, 120)
Smoking
No 21 0.78(0.35, 2.36) 48(0, 653)
Moderate 34 0.70(0.25, 1.30) 16(0, 136) NS
Heavy 17 0.94(0.43, 1.52) 40(16, 196)
Alcohol
No 30 0.60(0.40, 2.00) 30(5, 340)
Moderate 35 0.90(0.37, 1.61) 63(0, 242) NS
Heavy 7 0.83(0.49, 1.00) 10(0, 90)
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Fig 12 Correlation between H. pylori colonisation density in 
antrum and mucosal production of ROM measured by 
chemiluminescnece.
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Relationship between mucosal levels o f IL-8 and the mucosal production o f  
ROM
The relationship between mucosal levels of IL-8 and mucosal production of 
ROM measured by the chemiluminesence assay was assessed by the Pearson’s 
correlation analysis. There was a positive correlation between antral mucosal 
concentration of IL-8 and the mucosal production of ROM (1-O.6I, p<0.01)(Fig 
13).
Relationship between mucosal levels o f IL-8 and presence of cagA gene and 
expression o f VacA cytotoxin
Fig 14 and Table 10 show the correlation between antral mucosal protein levels of IL- 
8 and the presence of cagA gene in the isolates and VacA cytotoxin-producing status 
of strains of H, pylori. Median(interquartile) levels(pg/mg) of lL-8 (1.80(0.97, 2.99)) 
in patients infected with cagA+ve/VacA+ve strains were significantly higher than that 
in those with cagA-ve/VacA-ve strains(0.50(0.35, 1.20)) and in those without H. 
pylori infection(0.20(0.00, 0.70)). There was no significant difference in mucosal 
levels of lL-8 between those patients infected with cag A+ve/Vac A-ve 
strains(0.90(0.63, 2.10)) and those infected with cagA-ve/VacA- strains, although the 
fonner group showed higher mucosal lL-8 than patients without H. pylori infection. 
The mucosal IL-8 in patients infected with cagA-ve/VacA+ve strains(0.6(0.28, 1.75)), 
did not show any significant increase as compared to those infected with cagA- 
ve/VacA-ve strains or those without 77. pylori infection.
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Fig 13 Association between gastric mucosal levels of IL-8
and ROM
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Fig 14 Relationship between mucosal levels of IL-8 and VacA 
expression and possession of cagA gene of H. pylori strains. 
Medians, interquartile range and p values are shown.
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Relationship between mucosal production o f ROM and the expression o f  
VacA and cagA o f H. pylori
Mucosal ROM levels(median(interqiiartile)mv/niin/mg) were significantly 
higher in patients colonised with cagA+ve/VacA+ve strains(210(58, 730)) than that 
in those infected with cagA-ve/VacA-ve strains(30(8, 175), (p=0.004) and than that in 
those without H. pylori infection(0(0, 3))(p<0.0001). No significant difference was 
found in mucosal production of ROM between those patients infected with 
cagA+ve/VacA-ve strains and those infected with cag A-ve/VacA+ strains and those 
with cag A-ve/V acA-ve strains, although all those infected groups showed higher 
mucosal production of ROM than that in those patients without H. pylori infection(Fig 
15, Table 10).
Table 10 Relationship between the presence of cagA gene and expression of VacA 
cytotoxin by strains of H. pylori and mucosal production of IL-8 and ROM.
Patients’
groups
Characteristics of 
strains No
Mediant interquartile!
IL-8 (pg/mg) ROM{mv/min/mg)
1 VacA+ cagA+ 25 1.80(0.97, 2.99)* 210(58, 730)''
2 VacA - cagA+ 10 0.90(0.63, 2.10) 104(21,416)
3 VacA + cagA- 5 0.60(0.28, 1.75) 50(13, 1363)
4 VacA - cagA- 12 0.50(0.35, 1.20) 30(8, 175)
^p<0.05 compared to group 4 (cytotoxin-ve/cagA-).
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Fig 15 Relationship between mucosal production of ROM and 
expression of VacA and the possession of cagA of H. pylori. 
Medians, interquartile range and p values are shown.
Relationships between IL-8 production and mucosal inflammation
When antral mucosal inflammation was graded according to inflammatory cell 
infiltration, the mucosal IL-8 concentration(expressed as median pg/mg 
biopsy(interquartile)) was related to neutrophil infiltration; normal 0.20(0.0 to 
0.77); mild 0.55(0.40 to 1.24); moderate 0.93(0.53 to 1.70); severe 2.25(1.06 to 
4.30); (r=0.55, Fig 16). Higher IL-8 levels were also correlated with greater 
mononuclear cell infiltration: normal 0.10(0.00 to 0.35); mild 0.60(0.42 to
1.02); moderate 0.80(0.50 to 1.07); severe 1.50 (0.76 to 2.80);(i~0.42, p<0.01).
a0
Association o f ROM release and histological inflammation
Fig 17 shows that a greater CL response(expressed as median mv/min/mg 
biopsy(interquartile)) correlated with a higher infiltration of neutrophils: normal /|
0.0(0.0 to 12.3); mild 21.0(8.5 to 103.0); moderate 92.5(31 to 203.0); severe 
556.0(152.0 to 1531.0);(r=0.51). CL response also correlated with mononuclear 
cell infiltration: normal 0.0(0.0 to 1.0); mild 9.0(0.0 to 26.5); moderate 16.2(5.0 
to 43.5); severe 206.0(120.0 to 906.0);(r=0.39, p<0.01).
:
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Fig 16 Association between antral mucosal production of IL- 
8 and histological score of neutrophil infiltration. Medians 
and p values are shown.
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Fig 17 Antral mucosal production of ROM and histological 
score of neutrophil infiltration. Medians and p values are
shown.
Relationship between antral inflammation and expression of cagA gene and VacA 
When antral mucosal inflammation was assessed and scored according to the severity 
of infiltration of neutrophils and mononuclear cells, the neutrophil infiltration score 
was found significantly higher in patients infected with cagA+ve/VacA+ve 
strains(2.0(2.0, 3.0) than that in those infected with cag A-ve/V ac A-ve strains(l. 0(1.0, 
2.0))(p<0.05). There was no significant difference in mononuclear cell infiltration 
score between the two groups of patients(3.0(2.0, 3.0) vs 2.5(1.5, 3.0), p>0.05). There 
was no significant differences in inflammation score of neutrophils and mononuclear 
cells between patients infected with cagA+ve/VacA-ve strains and those with cagA- 
ve/VacA+ strains and those with cagA-ve/VacA-ve strains(Table 11).
Table 11 Relationship between bacterial virulence factors cytotoxin(tox) and cagA 
gene and antral mucosal inflammation.
Patient
groups
Characteristics of 
strains No
Mediantinterauartilel inflammation score
Neutrophils Mononuclear cells
1 Tox+ cagA+ 25 2.0(2.0, 3.0)* 3.0(2.0, 3.0)
2 Tox- cagA4- 10 2.0(1.0,3.0) 2.0(1.5, 3.0)
3 Tox+ cagA- 5 1.5(0.5, 2.0) 2.5(1.25,3.0)
4 Tox- cagA- 12 1.0(1.0, 2.0) 2.0(1.5, 3.0)
I
I-
■
* p<0.05 compared to group 4 (cytotoxin-ve/cagA-).
5.5 Discussion and conclusions
I
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In this study, it was shown that both mucosal production of IL-8 and ROM are 
increased in H. pylori infected patients. There is also a good correlation between
'
IL-8 concentration and ROM release in antral gastric mucosa. This suggests that 
local mucosal production of IL-8 in response to H, pylori infection does occur 
in vivo and may play an important role in attracting and activating 
phagocytes(both neutrophils and mononuclear cells) to release reactive oxygen 
metabolites; H. pylori itself may also secrete chemotactic factors for neutrophils 
(235,237).
It was shown that inflammatory cell infiltration is associated with mucosal 
production of IL-8 and ROM. This finding may have two implications. Firstly, 
it supports the hypothesis that IL-8 is actively involved in H. pylori induced 
inflammatory response by attracting neutrophils and mononuclear cells to the 
site of infection. Secondly, greater inflammatory cell infiltration and activation 
could produce more ROM and more extensive tissue damage[238,239,288].
Studies have been undertaken to investigate the possible component(s) of H.
f
pylori that induces IL-8 secretion in vitro(214,270,271). In vitro studies have 
shown that cytotoxin+ve/cagA+ve strains induced greater epithelial cell production of 
IL-8 than cytotoxin-ve/cgaA-ve strains(269), suggesting that the CagA'^ve/jox'*’'^  ^
phenotype of H. pylori is associated with enhanced IL-8 production. Subsequent 
studies using genetically defined cagA-ve or cag A-ve/vac A-ve isogenic mutants have 
suggested that neither cytotoxin nor the cagA gene product is directly involved in the 
stimulation of cytokine release(269,271). However, more recent studies suggest that 
the cagA gene is a marker for the presence of a group of genes(the cag pahtogenicity 
island) in type I strains, which may directly regulate the cytokine production(272).
«
«
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Limited studies are available which address the relationship between bacterial type 
and in vivo mucosal production of IL-8. Peek et al(266) demonstrated increased 
cytokine expression in gastric mucosa infected with cagA positive strains off/, pylori; 
although the patient population studied were predominantly male of an older age and 
included a subgroup of patients who were taking NSAID. In the current study, we 
have investigated the relationship between bacterial types including cagA genotype 
and cytotoxin-producing status and the mucosal production of IL-8 in a general 
patient population with dyspepsia in whom NSAID use was excluded. It has been 
shown that patients infected with VacA+ve/cagA+ve strains had significantly 
increased mucosal levels of IL-8 than those infected with VacA-ve/cagA-ve strains of 
H. pylori. It was also shown that the former group of patients had a significantly 
higher neutrophil infiltration score than that of the latter group. These results support 
the in vitro finding that cytotoxin+/cagA+ strains induced an enhanced IL-8 
production in epithelial cells(269) and the finding that patients with cagA+ve strains 
had heightened mucosal cytokine expression(266). There was no significant increase 
in IL-8 production in patients infected with cagA+ve/cytotoxin-ve strains over those 
patients infected with cag A-ve/cytotoxin-ve strains, although these patients showed 
higher IL-8 levels than those patients without H. pylori infection. This seems to 
contradict the in vitro finding showing that CagA+ve/cytotoxin-ve strains stimulated a 
significantly higher IL-8 production than those cag A-ve/cytotoxin-ve strains(270). 
The reason for this discrepancy between in vitro and in vivo findings is unclear. It is 
possible that there are differences between in vitro epithelial cell lines and in vivo 
human mucosal cells in their response to the bacterial stimulation. Although the 
expression of VacA(cytotoxin) by H. pylori is not a marker for the induction of IL-8,
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producers; s2/m2 strains were not toxin producers.
It was shown in this study that 80.6% of strains of H. pylori isolated from peptic ulcer 
patients were cagA+ve versus only 37.5% of strains from patients with non-ulcer
higher mucosal production of ROM compared to those infected with VacA- 
ve/cagA-ve strains of H. pylori^ supporting previous in vitro studies which
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its presence in combination with the cagA+ve genotype may represent a subgroup of 
strains of 77 pylori which stimulate a stronger cytokine release in vivo and induce 
more severe mucosal inflammation and tissue injury.
In this study, 71% of cag A+ve strains were shown to express cytotoxin(VacA), and 
83% cytotoxic strains were cagA+ve. These results were in accordance with previous
reports that in about 70% of 77 pylori strains, the cytotoxin expression and possession #0
of the cagA gene are correlated(215). The genetic basis for this correlation is unclear. | |
'■One study has reported that cagA status was concordant with vacA genotype in most 
strains studied: All cag A+ve strains were si vacA genotype; and all s2 strains were 
cagA-ve, whilst some cag A-ve strains were si vac A genotype(201). Atherton et 
al(201) has also shown the correlation between the cytotoxin(VacA) phenotypic 71
expression and the vac A genotypes: si/m l genotype strains were high cytotoxin
dyspepsia(p=0.005), supporting previous findings that cagA+ve strains of 77 pylori
are more associated with peptic ulceration than patients with chronic gastritis +
alone(210). We have also shown that 66.7% of strains from patients with peptic ulcer 
were cytotoxin positive( V ac A+ve) versus 37.5% of strains from patients with non­
ulcer dyspepsia(p=0.045), supporting previous reports that cytotoxinogenic strains of
77 pylori are more frequently found in patients with peptic ulcer disease( 189-191). IIt was also shown that patients infected with VacA+ve/cagA+ve strains had a
I
II
suggested that toxinogenic strains of H. pylori may induce an enhanced
neutrophil oxidative burst(294,295). The results also showed that antral H.
pylori colonisation density is an important determinant in ROM release,
confirming the results by Davies et al(297) that the infective load of H. pylori is
associated with the ROM production in the antral mucosa. Mucosal ROM
production was associated with histological inflammation. These results would
confirm the association between H. pylori infection and ROM production and
support the role of ROM in H. pylori-m&\\OQ& mucosal damage.
Recent studies have suggested that H. pylori cytotoxin, encoded by the VacA
gene, and the cytotoxin-associated protein(CagA) are important virulent factors,
.Both are considered to be important in the development of peptic ulcer. Clinical
;
and genetic analysis supports the hypothesis that there may be more virulent or
'ulcerogenic' strains which are more likely to cause ulceration(201,210). A
recent study by Atherton et al(206) has demonstrated some heterogeneity in the 
,VacA gene, by showing that H. pylori strains of VacA signal sequence type si a 
are particularly associated with enhanced gastric inflammation and duodenal
Îulceration. While the exact mechanism by which toxinogenic strains cause more 
severe mucosal damage is still unclear, increased production of mucosal ROM 
induced by toxinogenic strains may be important in this respect. In this study, 
we have shown that biopsies obtained from patients with duodenal ulcer had
relatively higher levels of antral ROM than those obtained from H. pylori
ir-
infected non-ulcer dyspeptic patients. This may be due to the fact that there 
were more toxin-producing strains in duodenal ulcer patients and these patients
ft
are more likely to have higher infective load of 77. pylori{9A).
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jIn in vitro studies, several H. pylori products have been shown to activate #
i
phagocytes to release ROM, including a 150KDa protein(/7. pylori neutrophil 
activating protein, HP-NAP), urease, lipopolysaccharides(LPS) and a 25-30KDa 
protein(l75,236,293,296). It is as yet unknown which factor(s) is responsible 
for the in vivo stimulation of phagocytes. The vacuolating cytotoxin or the 
CagA protein per se is unlikely to be the major factor to induce a significant SI
neutrophil activation(294). However, the results in this study that patients 
infected with VacA+ve/cagA+ve strains had relatively higher levels of mucosal
ROM compared to those infected with VacA-ve/cagA-ve strains may suggest
■?
j:'that the ability to induce phagocyte activation and mucosal ROM production is
co-expressed or more strongly expressed in certain cytotoxic/cagA+ve strains of +
4
H. pylori. |
' IIn conclusion, gastric mucosal production of IL-8 is associated with an 
infiltration of neutrophils and mononuclear cells and is correlated with ROM
Irelease, which suggest that IL-8 may be important in attracting and activating 
phagocytes to release ROM thereby causing mucosal damage in H. pylori 
colonised patients. VacA+ve/cagA+ve strains are associated with an enhanced 
production of mucosal IL-8 and ROM in vivo and correlate with a stronger infiltration #Iof neutrophils. The results support previous in vitro findings and suggest that f
enhanced mucosal production of IL-8 and its role in neutrophil chemotaxis and 
activation could be important in the development of gastroduodenal inflanunation and 
peptic ulcer disease induced by VacA+ve/cagA+ve strains of H. pylori.
II 
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CHAPTER 6
Mucosal levels of specific IgA, toxinogenicity of Helicobacter pylori 
and gastric inflammation
6.1 Introduction
Generation of mucosal IgA is an important local immune defence mechanism. H. 
pylori induces a significant IgA response in antral mucosa in infected 
patients(274,275). Despite the persistence of a local and systemic immune response, 
H. pylori is not eliminated. However, animal studies have shown that repetitive oral 
immunisation with H. pylori antigens and cholera toxin induced a strong local IgA 
anti-77, pylori response in mice and feiTets. Mice can be protected from infection by
77. felis by immunisation with sonicated bacterial extracts or recombinant urease(299- 
301). Recent studies have also shown that oral administration of purified urease in 
combination with cholera toxin to mice or feinet, resulted in eradication of the bacteria 
in significant numbers of mice or ferrets(302,303). These results suggest that the 
mucosal IgA antibodies may have a protective role. Although the mucosal IgA 
antibodies failed to eliminate the organism in man, it may play a role in limiting 77. 
pylori induced mucosal damage. Studies have suggested that cagA+ve or 
cytotoxin+ve strains of 77. pylori are associated with a more serious pathology such as 
peptic ulcer disease and more active mucosal inflammation. There is little information 
available relating to specific IgA in response to toxinogenic and non-toxinogenic 
strains of 77. pylori and disease activity.
6.2 Aims
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To investigate whether any association exists between mucosal levels of H. pylori 
IgA, toxinogenicity of H. pylori, and mucosal inflammation.
6.3 Patients and experimental design 
Patients
52 dyspeptic patients undergoing endoscopy were recruited. They include 28 patients
with peptic ulcer(25 duodenal ulcer, 3 gastric ulcer) and 24 with non-ulcer
dyspepsia(NUD). Patients who had had eradication therapy or taken non-steroidal
anti-inflammatory dmgs(NSAID) were excluded h'om the study. Patients were also
advised to stop any anti-acid treatment two weeks before endoscopy. During
endoscopy, biopsies were taken for histology, H. pylori culture and measurement of
.mucosal IgA H. pylori antibodies. Detailed methods were described in chapter 2.
6.4 RESULTS
H, pylori in fection and mucosal IgA H. pylori antibodies
All 28 peptic ulcer patients and 10 of 24 of those with non-ulcer dyspepsia were 
infected with H. pylori. Antral mucosal IgA H. pylori antibodies were detectable in 
35 of 38 patients with H. pylori infection, with a median(interquartile) level of 
220.0(147.5, 531.0), while in those 14 patients without H. pylori infection, the IgA
antibody was detectable at a low level in only one.
No conelation was seen between mucosal IgA H. pylori antibodies and patients’ sex.
smoking habits and alcohol consumption; nor was any found between patients’ age 
and the antibody level, although in those below the age of 30 displayed a slight lower 
levels of IgA compared to those aged between 31 to 40 years(p=0.032)(Table 12). 
There was no significant difference in the mucosal IgA antibodies of patients with
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peptic ulcer and those with non-ulcer dyspepsia infected with H. pylori (235(165, 620) 
vs 153(34, 345), NS).
Table 12 Demographic details of patients in relation to mucosal levels of H. 
pylori IgA(OD45 Onmx 1000).
Patient No H. pylori IgA 
(Median(IQ range)) p value
Sex
Male 18 255(168, 643)
Female 20 190(45, 316) 0.12(NS)
Age
20-30 7 69.0(0.0, 260.0)
31-40 12 313.0(154.5, 735.0) *0.032
41-50 7 235.0(185.0, 659.0) " 0.08(NS)
51-60 6 219.0(128.5,395.0) *0.12(NS)
>61 6 260.0(129.0, 539.0) *0.11(NS)
Smoking habit
No 16 240(160, 713)
Moderate 16 234(92, 420) 0.8(NS)
Heavy 6 230(130, 946)
Alcohol consumption
None 20 197(115, 574) -
Moderate 15 260(115,574) 0.6(NS)
Heavy 3 144(128, 135)
compared to age group 20-30.
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Mucosal TgA antibodies and toxinoginicitv o f H. pylori
H. pylori isolates from the 38 infected patients were analysed for the expression of 
VacA cytotoxin and the possession of cagA gene. Table 13 summaries the mucosal 
levels of IgA H. pylori antibodies in different patients colonised with H. pylori strains 
with or without the VacA or cagA. There was no significant difference in mucosal 
levels of the IgA antibodies between patients infected with cytotoxin+ve or cagA+ve 
strains and those with toxin-ve or cagA-ve strains of H, pylori.
Table 13 Antral mucosal levels of IgA H. pylori antibodies in patients with H. 
pylori infection with reference to toxinogenicity of strains
Strains associated 
with infection
No Mucosal IgA antibodies(OD*1000) 
(Median(IQ))
Toxin +ve 24 219.0(71.7, 348.0)
Toxin -ve 14 260.0(148.0,565.0)
p = 0.34(NS)
cagA +ve 8 234.5(107.0,510.5)
cagA -ve 30 220.0(90.0, 505.0)
p = 0.51(NS)
Mucosal TgA H. pylori antibodies and mucosal inflammation
Wlien antral mucosal inflammation was assessed according to the degree of 
infiltration of neutrophils and mononuclear cells, there was no significant correlation 
between the mucosal levels of IgA antibodies and mononuclear cell infiltration
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score(Fig 18). However, the IgA levels in those patients with severe neutrophil 
infiltration(neutrophil score: 3) were lower than those with mild and moderate 
infiltration(neutrophil score: 1 and 2)(Fig 19).
6.5 Discussion and Conclusions
It was found in this study that most infected patients had raised mucosal levels of H.
pylori IgA. While there were large variations in the mucosal level of IgA among 
patients, there was no significant difference between patients infected with 
toxinogenic strains(either VacA or cagA) and those with strains not expressing either 
VacA or cagA. There was no significant correlation between patients’ age and the 
mucosal levels of IgA; although a slight lower level of the IgA antibodies in patients 
below the age of 30 was apparent. Lack of correlation between the toxinogenicity of
H. pylori and mucosal IgA suggest that the variation in host’s immune response may
I
Ï 
.be more important and the time for which patient had been infected may also be
iI
relevant.
Although animal studies have shown that oral immunisation with H. pylori antigens 
induced a significant secretory IgA response and protected mice firoin infection of H. 
felis and even eradicated the bacteria from the infected mice, the role of mucosal IgA 
antibodies in the immunopathology of H. pylori-xoïdiiQà gastroduodenal disease in 
man is unclear. Mucosal secretory IgA has been suggested to be important in 
inhibiting antigen uptake, blocking bacterial adherence and motility of the 
organism and also in toxin neutralisation(278). It has been shown that the IgA
'
inhibits the cell vacuolation induced by H. pylori cytotoxin in vitro(279).
Previous studies also showed that H. pylori in gastric biopsy was coated with
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IgA, but only a proportion of the bacteria were coated(273). So it is possible 
that some bacteria evaded the IgA defence mechanism for some reason. Current 
information on the association between the mucosal antibodies and the disease 
activity is limited. Serum IgG titres were shown to be correlated with the 
severity of inflammation both in the antrum and in the body of the 
stomach(280). Serum IgG responses to the 54KD heat shock protein and to the 
vacuolating cytotoxin were correlated with acute mucosal inflammation(281). 
Interestingly, the serum IgA responses to whole-cell sonicate of H. pylori and to 
the cytotoxin were inversely related to chronic inflammatory scores(281). In this 
study, it was found that patients whose mucosa was severely infiltrated with 
neutrophils displayed lower levels of IgA than in those patients whose mucosa had 
mild to moderate neutrophil infiltration. Previous studies have shown that toxinogenic 
strains of H. pylori are associated with a stronger mucosal inflammatory response. 
These results may suggest that the pro-inflammatory property of toxinogenic strains 
may induce more severe inflammation with intense neutrophil infiltration, which 
could damage the integrity of the mucosa(297,298) and compromise the mucosal IgA 
defence. Another possibility may be that an insufficient IgA response in some patients 
allows more bacterial colonisation and more severe mucosal damage.
In conclusion, H. pylori infection induced a significant local mucosal IgA response in 
most infected patients. The level of the IgA antibodies does not appear to be 
correlated with the toxinogenicity of H. pylori. However, the pro-inflammatory 
property of toxinogenic strains may induce severe inflammation which may 
compromise the mucosal IgA defence and rendering the mucosa susceptible to further 
damage.
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Chapter 7
Effect of Helicobacter pylori eradication therapy on mucosal levels of 
interleukin 8, reactive oxygen metabolites and immunoglobulin A
7.1 Introduction
Recent studies have established the associations between H. pylori infection and 
chi'onic gastritis, peptic ulceration, and increased risk of gastric lymphoma of mucosa- 
associated lymphoid tissue(MALT) type and possibly gastric adenocarcinoma(l-4,98- 
103). Eradication of the bacterium leads to the significant reduction in the level of 
gastric inflammation, the cure of the ulcer and the regression in most low-grade 
gastric ■ MALT lymphomas. Studies have suggested that H. pylori-màucQà local 
immuno-inflammatory reaction, including mucosal production of interleukin 8(IL-8), 
reactive oxygen metabolites (ROM) and immunoglobulin A(IgA), may be important 
in H. py/on-associated tissue damage(37,176,216,244,297,298). IgA is a predominant 
isotype of immunoglobulins in mucosal defence(304). H. pylori induces a strong local 
mucosal IgA response, although its role in the pathogenesis is unclear(274,277). There 
is little information on the effect of eradication of H. pylori on the mucosal immuno- 
inflammatory responses.
7.2 Aim of study
To investigate if changes occur after the eradication of H. pylori on the mucosal levels 
of IL-8, ROM and IgA.
7.3 Patients and experimental design 
Patients
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24 endoscoped patients with confinned duodenal ulcer disease were recruited into the 
study. Patients who had received any previous H. pylori eradication therapy, those 
who had had previous gastric surgery and those receiving non-steroidal anti- 
inflammatoiy drugs were excluded. Patients had been advised to stop any anti-acid 
drug treatment at least two weeks before endoscopy. During endoscopy, gastric antral 
biopsies were taken using the same size forceps from similar topographical sites at 
each endoscopy for histology, H. pylori culture, CLO test, and chemiluminescence 
(CL, measuring ROM). For histological examination, inflammation and H. pylori 
colonisation were assessed by an independent pathologist.
Measurements of IL~8 and IgA
Each biopsy was weighed and placed in an Eppendorf tube containing phosphate 
buffered saline(PBS, pH 7.3). The volume of the PBS in each tube was adjusted to 1 
mg of biopsy in lOOpl of PBS. It was then homogenised sepai'ately by a tissue grinder 
at 4°C. The homogenate was centrifuged at 2000g for 10 min. The supernatant was 
removed and stored at -70°C, until the measurements of IL-8 and IgA.
IL-8 was measured by an ELISA(Bio-Wliittaker, UK), following the methods 
described previously(Chapter 2) . The results were expressed as pg/mg biopsy. 
Mucosal H. pylori antibodies were measured by an ELISA(Signia, St Louis, 
USA), in duplicate according to the instructions of the manufacturer as described 
in methods(chapter 2). The results were expressed as OD450nmxl000.
Detection of reactive oxygen metabolites(ROM)
Mucosal production of ROM was measured by Luminol-enhanced 
chemiluminescence(CL) as described in chapter 2. The results were expressed as 
mv/min/mg of biopsy after subtraction of the background.
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ITreatment
Patients with duodenal ulcer and infected with H. pylori were treated with 
lansoprazole 30 mg daily for four weeks, metronidazole 200 mg three times daily for 
one week and clarithromycin 250 mg tlrroe times daily for one week. Patients were 
invited to have a second endoscopy one month after completing the treatment and 
biopsies taken for the above tests.
Statistical Analysis:
Wilcoxon’s matched pairs test was used to compare the differences before and after 
treatment.
7.4 Results
Effect o f treatment
Before treatment, all 24 patients with duodenal ulcer had antral infection with H.
pylori. After treatment, IT. pylori was eradicated in 20 (83.3%); ulcer healing 
occuned in 22.
Effect of eradication on mucosal levels of IL-8, ROM, IgA and mucosal sinflammation
In 20 patients in whom H. pylori was successfully eradicated, there was a significant 
reduction in median(interquartile) mucosal ROM(mv/mg/min) levels(153(53,595) to 
20(0, 30), (<0.001) (Fig 20). There was a less prominent but significant decrease in 
mucosal levels of IL-8(pg/mg) (1.6(0.9, 3.0) to 0.6(0.1, 1.9), p=0.02)(Fig 21). There 
was a slight but not significant reduction in IgA levels (235(124,550) to 165(36, 265), 
p=0.06)(Fig 22).
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A significant improvement was seen in histological appearance with the virtual 
disappearance of the neutrophil infiltrate in all patients in whom H. pylori was 
eradicated (p<0.0001), and with a decrease in median(interquartile) mononuclear cell 
infiltration score from 2.5(2.0, 3.0) to 1.5(1.0, 2.0)(p<0.05).
In those four patients who remained H. pylori positive after treatment, there were no 
significant changes in the levels of mucosal IL-8, ROM or in mucosal 
inflammation(p>0.05). (Table 14)
Table 14 Mucosal levels of IL-8 , ROM and mucosal before and after treatment in 
four patients who remained H. pylori positive.
Patient
JlMpg/mg). 
before after
ROM! mv/m in/mg) 
before after
PMN score 
before after
Mononuclear cell score 
before after
1 1.6 2.0 200 500 2.0 2.0 3.0 3.0
2 1.0 0.9 180 150 2,0 1.0 2.0 2.0
3 2.6 4.0 340 360 3.0 3.0 3.0 3.0
4 1.8 2.0 974 480 3.0 3.0 3.0 3.0
7.5 Discussion and Conclusion
It was shown that one month after eradication of K  pylori, a significant reduction in 
mucosal ROM with a median from 153 to 20(mv/mg/min) was observed. There was 
also a moderate reduction in mucosal levels of IL-8 with a median from 1.67 to
0.61 (pg/mg). Histologically, eradication of H. pylori is accompanied by the virtual 
disappearance of mucosal neutrophils and a moderate reduction in chronic
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inflammatory cells. These findings support the roles of IL-8 and ROM in H. pylori â
infection. IgA antibodies to H, pylori were also reduced after eradication therapy with 
a median antibody titre from 235 to 165, although the IgA levels in some patients 
remained high.
A prominent histological feature associated with H. pylori infection is an infiltration 
of neutrophils and monocytes. Studies have suggested that H. pylori secretes certain
%
products, which are chemotactic and/or capable of induction of the oxidative burst of ft
phagocytes(235-237). H, pylori infection in the gastric mucosa also stimulates the i
mucosal cells to produce cytokines such as IL-8, IL-1, IL-6 and tumour necrosis 
factor(TNF)(261,264-267). These cytokines, especially IL-8 may be important in the 
trafficking and activation of phagocytes, which are a major source of ROM(238). The f
mucosal damage observed in patients with clu'onic gastritis may be caused by
ROM(244,245). Therefore, if the above hypothesis is correct, eradication of 77 pylori
should substantially reduce the mucosal production of IL-8 and ROM. The significant
decrease in ROM production seen in this study after successful eradication of 77 |
' f
pylori, accompanied by the disappearance of neutrophils and a moderate decrease in 
monocytes numbers, would confirm the importance of ROM in 77 j^/ori-related "%'!imucosal damage, and would also support the notion the neutrophils are the main 
source of ROM. The mucosal levels of IL-8 were also reduced one month after f
completion of eradication therapy, but less significantly than ROM. The mucosal IL-8 
concentration in some patients still remained relatively high one month after 
treatment. This finding contrasts with that of Moss et al(265) in which mucosal f ;
mRNA gene expression of IL-8 were determined and found to be quickly reduced to 
normal after eradication. The differences in the sensitivity of the methods used may
t
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explain the apparently conflicting results(265). Previous studies suggested that IL-8 is 
extremely long-lived and is resistant to both high temperature and enzymatic 
degradation(252,257). In addition, a single stimulus may induce continuous 
production of IL-8 protein and persisting levels of IL-8 mRNA in vitro. It was also 
shown that the kinetics of IL-8 synthesis is prolonged in contrast with that of other 
cytokines such as TNP and IL-6(257,258). A biphasic production of IL-8 in 
lipopolysaccharides(LPS)-stimulated human whole blood was observed(257). A
second phase of IL-8 synthesis, induced by early cytokine mediators(TNF and IL-1), 
lasted much longer than the first phase induced by LPS itself. So the slow decline in 
IL-8 levels seen in some patients after bacterial eradication may reflect the relatively 
prolonged kinetics of the cytokine.
I
i
I
Mucosal IgA is the most important Ig isotype in local immune defence. Although H. 
pylori induced IgA secretion does not appear to eliminate the infection, it may play 
some role in limiting damage caused by the bacterium. Animal studies using H. pylori
%
urease preparations as oral vaccines against H. pylori infection suggested a protective
role for mucosal secretory IgA(299-303). Previous studies have shown that the
reinfection rate after eradication is very low in a two year follow~up(161,305).
Another study by Miehlke et al(306) showed that the reinfection rate at 1, 2 and 5 
.years after eradication was 3.2, 3.2 and 9.7% respectively, and most of the duodenal 
ulcer relapses appeared to be associated with H. pylori reinfection. It was shown in 
this study that although the mucosal 77 pylori IgA levels decreased after eradication, it 
remained high in most patients one month after eradication. Sustained synthesis of 
mucosal IgA after eradication may be important in preventing patients from 
reinfection.
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CHAPTER 8
General discussion and conclusions
The studies in this thesis have investigated the importance of H. pylori 
toxinogenicity and the host immuno-inflammatory responses in the pathogenesis 
of chronic gastritis and peptic ulcer.
Chapter 1 reviewed the current understanding about the pathogenesis of chronic 
gastritis and peptic ulceration, in particular the importance of H. pylori 
infection, and also the involvement of host immune response including 
neutrophil activation, mucosal production of IL-8, ROM, and immunoglob'ulin.
Chapter 2 describes the general methods employed in the studies. The 
subsequent chapters have investigated: whether cytotoxin-producing strains of H. 
pylori are associated with the generation of an oxidative burst in neutrophils(chapter 
3); the possible components of H. pylori which induce the neutrophil oxidative
iburst(chapter 4); whether there is any relationship between in vivo mucosal f
production IL-8 and neutrophil-derived reactive oxygen metabolites(ROM) release 
and whether mucosal levels of IL-8 and ROM are increased in those patients infected 
with toxinogenic strains(chapter 5); the relationship between mucosal IgA H. pylori
- j ,
antibodies and bacterial toxinogenicity and disease activity(chapter 6); and lastly the 
effect of eradication therapy of H. pylori on the mucosal levels of IL-8, ROM and 
IgA(chapter 7). |
The important points can be summarised as follows:
1 Cytotoxin positive strains of H. pylori displayed an enhanced induction of the 
oxidative burst in neutrophils compared to toxin negative strains fi'om patients with 
chronic gastritis only. Some non-cytotoxin-producing strains also induced a neutrophil
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oxidative burst, suggesting that some component(s) other than cytotoxin itself may be 
responsible for the neutrophil activation. It is suggested that the neutrophil activating i
property may be more strongly expressed in most toxinogenic strains of H. pylori. The 
ability of some strains of H. pylori to produce cytotoxin and to induce the oxidative 
burst in neutrophils may be important in the pathogenesis of peptic ulcer disease.
2 Several H. pylori products mainly proteins may be involved in the 
activation of neutrophils. H, pylori cytotoxin and urease do not appear to be the 
active components for the neutrophil activation.
3 A good correlation between IL-8 concentration and ROM release in antral
■igastric mucosa suggests that local mucosal production of IL-8 in response to H. 
pylori infection may play an important role in attracting and activating 
phagocytes to release ROM. More intense inflammatory cell infiltration and 
activation may produce more ROM and cause more severe tissue damage. In 
line with the in vitro finding that VacA+/cagA+ strains induced an enlianced IL-8 
production in epithelial cells, patients infected with VacA+ve/cagA+ve strains had
:::
significantly higher mucosal levels of IL-8 and ROM than those infected with Vac A- 
.ve/cagA-ve strains of H. pylori. The fomier group of patients also showed a 
.significantly higher neutrophil infiltration score than that of the latter group.
CagA+ve/VacA+ve strains may represent a subgroup of strains of H. pylori which
.stimulate a stronger cytokine release in vivo and induce more severe mucosal 
inflammation and tissue injuiy. More toxinogenic strains were isolated hom patients 
with peptic ulcer compared to those with non-ulcer dyspepsia (NUD). The results 
support the hypothesis that there may be more virulent or 'ulcerogenic' strains. 
Enlianced mucosal production of IL-8 and ROM could be important in
iI13V
__
more important in stimulating an immune response. The time of infection may also be
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VacA+ve/cagA+ve strains of H. /?y/on'-induced gastroduodenal inflammation and in 
the development of peptic ulcer disease.
4 Although most infected patients had raised mucosal levels of IgA antibodies, 
there were big variations in the level of IgA antibodies among patients. There was no 
significant difference between patients infected with VacA+ve or cagA+ve strains and 
those infected with VacA-ve or cagA-ve strains. This suggests that differences in
I
individual host response or some other bacterial factors other than cagA/VacA may be |
relevant. The finding that the mucosa with the highest infiltration score of neutrophils f
;
displayed lower level of IgA compared to the mucosa with mild to moderate
infiltration may suggest that severe mucosal inflammation could damage the integrity
,of the mucosa and compromise the mucosal defence.
5 A significant reduction in mucosal ROM and IL-8 accompanied by a 
substantial improvement in histological inflammation support the roles of IL-8 and IROM in H. pylori infection. A sustained level of mucosal specific IgA after
■
eradication of H. pylori might be important in preventing reinfection by the bacterium.
In conclusion, toxinogenic strains of H. pylori are more likely to induce a 
stronger host inflammatory response by inducing an enhanced neutrophil | |
oxidative burst and an enhanced mucosal production of IL-8 and ROM, leading 
to a more prominent mucosal inflammatory cell reaction. More severe mucosal A
inflammation may damage the mucosal IgA defence, rendering the mucosa more 
susceptible to infection and injury. These findings may be important in the 
pathogenesis of H. /jy/ori-related active gastritis and peptic ulcer disease.
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